[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_83289c5a-0e1a-4089-90d0-8447ef02c8ba":656,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:83289c5a-0e1a-4089-90d0-8447ef02c8ba,\"}":671},{"meta":4,"data":6},{"total":5},"117",[7,60,176,207,299,413,445,480,543,572],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":29,"subjectFields":30,"manageAffiliations":31,"indexDatabases":32,"url":33,"thumbnailPath":34,"statistic":35,"gsStatistic":26,"type":26,"analyzePriority":26},"5a09599f-54d1-44c3-8f16-3847ac552024","2023-08-17T04:28:50.832+00:00","2025-10-13T23:58:52.517+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Truy%E1%BB%81n-nhi%E1%BB%85m-Vi%E1%BB%87t-Nam",{"country":14,"issn":16,"introduce":18,"title":21},{"VOID":15},"VN",{"VOID":17},"08667829",{"EN":19,"VI":20},"{\"ops\":[{\"insert\":\"Vietnam Journal of Infectious Diseases is a social - professional forum of the Vietnam Society for Infectious Diseases, whose responsibility is to introduce the researches, the scientific advances in Vietnam and from the world; to contribute to the improvement of knowledges for health care staffs about clinic, treatment, guideline, prevention, epidemiology for infectious diseases, HIV\u002FAIDS and community health care; to provide, exchange and publish scientific information to the public accurately and promptly.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Vietnam Journal of Infectious Diseases publishes in the whole country; serves the professional work for researchers, clinical staffs, administrators, undergraduate and postgraduate students who are working and studying in the infections, tropical diseases and HIV\u002FAIDS from central to local levels, also organizations and individuals in the world who are interested in infectious and tropical diseases and prevention for HIV\u002FAIDS.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Editor in Chief:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Kinh. - Chairman of Editorial Board\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Mui.\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Headquarter:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Address:\"},{\"insert\":\" Level 6, National Hospital for Tropical Diseases, No. 78 Giai Phong Street, Dong Da District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tel:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913552672\"},\"insert\":\"0913552672\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Bank account:\"},{\"insert\":\" 0021000275119, Vietcombank Hanoi Branch. Transaction office No. 7, 402 Tran Khat Chan, Hai Ba Trung District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Truyền nhiễm Việt Nam là cơ quan ngôn luận của Hội Truyền nhiễm Việt Nam, chịu sự lãnh đạo, chỉ đạo trực tiếp của Thường vụ Ban Chấp hành Hội Truyền nhiễm Việt Nam; sự kiểm tra, giám sát về nghiệp vụ báo chí của các cơ quan chức năng quản lý báo chí thuộc Bộ Thông tin và Truyền thông và Ban Tuyên giáo Trung ương Đảng.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí có trách nhiệm giới thiệu các công trình nghiên cứu khoa học, những tiến bộ khoa học trên thế giới và trong nước, góp phần nâng cao kiến thức khoa học cho cán bộ y tế về lâm sàng, điều trị, hướng dẫn, dự phòng, dịch tễ học các bệnh truyền nhiễm, HIV\u002FAIDS và chăm sóc sức khỏe cộng đồng; cung cấp, trao đổi, phổ biến các thông tin khoa học tới công chúng chính xác và kịp thời.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí xuất bản 03 tháng\u002F01 kỳ và được phát hành qua Bưu điện và tự phát hành trong phạm vi toàn quốc.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Lãnh đạo Tạp chí: \"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Tổng Biên tập: ThS.BSCKII Nguyễn Trung Cấp\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Phó Tổng Biên tập:\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"            TS.BSCKII Phạm Ngọc Thạch\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Trụ sở tòa soạn:\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Địa chỉ: Tầng 6, Bệnh viện Bệnh Nhiệt đới Trung ương, 78 đường Giải Phóng, phường Phương Mai, quận Đống Đa, thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Điện thoại:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\" - \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tài khoản:\"},{\"insert\":\" Số 0021000275119 Ngân hàng Ngoại thương Việt Nam, chi nhánh Hà Nội (Vietcombank Hà Nội). Phòng giao dịch số 7, 402 Trần Khát Chân, quận Hai Bà Trưng, Thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":22,"VI":23},"Vietnam Journal of Infectious Diseases","Tạp chí Truyền nhiễm Việt Nam","PUBLISHER","VERIFIED",null,"Admin update database","PENDING",51,[],[],[],"https:\u002F\u002Ftruyennhiemvietnam.vn\u002Findex.php\u002Fvjid","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F5a09599f-54d1-44c3-8f16-3847ac552024\u002Fadb0e52bf25e0de580fd4289519cb8bf.jpg",{"impactFactor":36,"impactFactorByYear":37,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":41,"totalPublicationByYear":42,"totalCitation":48,"totalCitationByYear":49,"totalCitationPerPublication":54,"totalCitationPerPublicationByYear":55,"hindexLast5Year":59,"hindex":59},0,{"2022":38,"2023":39,"2024":40},0.01,0.03,0.13,315,{"2020":43,"2021":44,"2022":45,"2023":46,"2024":47},63,58,57,65,72,43,{"2020":50,"2021":51,"2022":52,"2023":53},8,15,9,11,0.14,{"2020":40,"2021":56,"2022":57,"2023":58},0.26,0.16,0.17,3,{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":24,"verifyStatus":25,"verifyTime":78,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":79,"subjectFields":80,"manageAffiliations":81,"indexDatabases":136,"url":137,"thumbnailPath":26,"statistic":138,"gsStatistic":155,"type":175,"analyzePriority":26},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00","2026-06-18T23:33:57.141+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":67,"issn":68,"introduce":70,"title":73,"gsId":76},{"VOID":15},{"VOID":69},"23541210",{"EN":71,"VI":72},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"EN":74,"VI":75},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"VOID":77},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",32,[],[82],{"id":83,"createTime":84,"updateTime":85,"relativeEntities":86,"slug":87,"properties":88,"entityType":98,"verifyStatus":25,"verifyTime":99,"verifyNote":26,"syncStatus":28,"languages":100,"translateLanguages":26,"viewCount":103,"url":104,"parentIds":105,"statistic":106},"6413896b-eca9-442b-a73f-182a58a0ce40","2023-06-12T14:59:13.446+00:00","2026-06-19T02:29:32.871+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Y-D%C6%B0%E1%BB%A3c-C%E1%BA%A7n-Th%C6%A1",{"country":89,"title":90,"address":93,"abbreviation":96},{"VOID":15},{"EN":91,"VI":92},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"VI":94,"EN":95},"Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam","No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam",{"VOID":97},"ctump","AFFILIATION","2023-08-01T14:07:27.977+00:00",[101,102],"VI","EN",12,"http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":107,"i10Index":111,"i10IndexLast5Year":59,"totalPublication":112,"totalPublicationByYear":113,"totalCitation":122,"totalCitationByYear":123,"totalCitationPerPublication":128,"totalCitationPerPublicationByYear":129,"hindexLast5Year":135,"hindex":135},{"2022":108,"2023":109,"2024":110,"2025":38},0.1,0.05,0.07,4,1489,{"2013":114,"2014":115,"2015":115,"2016":111,"2017":115,"2018":59,"2019":114,"2020":116,"2021":117,"2022":118,"2023":119,"2024":120,"2025":121,"2026":111},2,1,10,84,281,680,260,156,313,{"2013":59,"2014":114,"2018":124,"2021":125,"2022":126,"2023":127},17,36,123,132,0.21,{"2013":130,"2014":114,"2018":131,"2021":132,"2022":133,"2023":134},1.5,5.67,0.43,0.44,0.19,6,[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":36,"impactFactorByYear":139,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":140,"totalPublicationByYear":141,"totalCitation":147,"totalCitationByYear":148,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":152,"hindexLast5Year":135,"hindex":135},{"2022":38,"2023":36,"2024":39,"2025":38},1956,{"0":114,"2019":114,"2020":50,"2021":142,"2022":143,"2023":144,"2024":145,"2025":146},76,403,789,305,371,524,{"0":114,"2019":135,"2021":124,"2022":149,"2023":150,"2024":111,"2025":114},287,206,0.27,{"0":115,"2019":59,"2021":153,"2022":154,"2023":56,"2024":38,"2025":38},0.22,0.71,{"impactFactor":26,"impactFactorByYear":26,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":156,"totalPublicationByYear":157,"totalCitation":163,"totalCitationByYear":164,"totalCitationPerPublication":169,"totalCitationPerPublicationByYear":170,"hindexLast5Year":135,"hindex":135},461,{"0":158,"2019":114,"2021":159,"2022":160,"2023":161,"2024":158,"2025":162},7,37,296,107,5,419,{"2021":59,"2022":59,"2023":165,"2024":166,"2025":167,"2026":168},71,126,171,41,0.91,{"2021":171,"2022":38,"2023":172,"2024":173,"2025":174},0.08,0.66,18,34.2,"JOURNAL",{"id":177,"createTime":178,"updateTime":179,"relativeEntities":180,"slug":181,"properties":182,"entityType":24,"verifyStatus":25,"verifyTime":193,"verifyNote":26,"syncStatus":28,"languages":194,"translateLanguages":26,"viewCount":36,"subjectFields":195,"manageAffiliations":196,"indexDatabases":197,"url":198,"thumbnailPath":26,"statistic":26,"gsStatistic":199,"type":175,"analyzePriority":26},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-06-18T23:33:41.667+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":183,"introduce":184,"gsId":186,"title":188,"issn":191},{"VOID":15},{"EN":185},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":187},"MS2_GJQAAAAJ",{"VI":189,"EN":190},"Tạp chí Khoa học và Công nghệ nhiệt đới","Journal of Tropical Science and Engineering",{"VOID":192},"08667535","2025-10-27T06:27:25.058+00:00",[101,102],[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":200,"totalPublicationByYear":201,"totalCitation":161,"totalCitationByYear":203,"totalCitationPerPublication":153,"totalCitationPerPublicationByYear":205,"hindexLast5Year":114,"hindex":114},481,{"0":115,"2020":115,"2021":115,"2022":114,"2024":115,"2025":202,"2026":115},474,{"2017":114,"2018":115,"2019":111,"2020":162,"2021":162,"2022":116,"2023":50,"2024":162,"2025":204,"2026":52},52,{"2020":162,"2021":162,"2022":162,"2024":162,"2025":206,"2026":52},0.11,{"id":208,"createTime":209,"updateTime":210,"relativeEntities":211,"slug":212,"properties":213,"entityType":24,"verifyStatus":25,"verifyTime":221,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":226,"thumbnailPath":26,"statistic":227,"gsStatistic":276,"type":175,"analyzePriority":26},"a3d1e82a-57e2-40f9-940e-f5fa8b9ef64a","2023-06-01T07:11:26.039+00:00","2026-06-18T23:33:28.573+00:00",[],"VNU-Journal-of-Science-Earth-and-Environmental-Sciences",{"issn":214,"title":216,"country":218,"gsId":219},{"VOID":215},"26159279",{"EN":217},"VNU Journal of Science: Earth and Environmental Sciences",{"VOID":15},{"VOID":220},"UmXD8vEAAAAJ","2023-06-01T07:17:59.210+00:00",27,[],[],[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FEES",{"impactFactor":36,"impactFactorByYear":228,"i10Index":234,"i10IndexLast5Year":36,"totalPublication":235,"totalPublicationByYear":236,"totalCitation":246,"totalCitationByYear":247,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":262,"hindexLast5Year":103,"hindex":103},{"2010":229,"2012":40,"2013":230,"2014":230,"2015":231,"2016":54,"2017":171,"2018":109,"2019":110,"2020":57,"2021":232,"2022":233,"2023":151,"2024":58},0.02,0.04,0.09,0.31,0.4,19,656,{"2008":237,"2009":238,"2010":239,"2011":238,"2012":240,"2013":241,"2014":239,"2015":242,"2016":243,"2017":244,"2018":245,"2019":165,"2020":125,"2021":168,"2022":125,"2023":222,"2024":111},23,24,22,28,25,20,146,29,78,1038,{"2008":248,"2009":249,"2010":250,"2011":251,"2012":252,"2013":253,"2014":254,"2015":255,"2016":256,"2017":257,"2018":161,"2019":258,"2020":259,"2021":29,"2022":260},119,64,66,86,38,73,59,31,129,39,97,53,26,1.58,{"2008":263,"2009":264,"2010":59,"2011":265,"2012":266,"2013":267,"2014":268,"2015":269,"2016":270,"2017":271,"2018":272,"2019":272,"2020":273,"2021":274,"2022":275},5.17,2.67,3.58,1.36,2.92,2.68,1.55,0.88,1.34,1.37,1.47,1.24,0.72,{"impactFactor":26,"impactFactorByYear":26,"i10Index":173,"i10IndexLast5Year":135,"totalPublication":277,"totalPublicationByYear":278,"totalCitation":279,"totalCitationByYear":280,"totalCitationPerPublication":288,"totalCitationPerPublicationByYear":289,"hindexLast5Year":158,"hindex":298},113,{"2007":114,"2008":103,"2009":173,"2010":116,"2011":51,"2012":239,"2013":103,"2014":162,"2015":53,"2016":135},616,{"2009":162,"2010":114,"2011":52,"2012":124,"2013":222,"2014":255,"2015":48,"2016":44,"2017":281,"2018":282,"2019":259,"2020":283,"2021":284,"2022":285,"2023":286,"2024":257,"2025":287,"2026":59},54,60,49,47,34,44,33,5.45,{"2009":290,"2010":291,"2011":292,"2012":293,"2013":294,"2014":295,"2015":296,"2016":297},0.28,0.2,0.6,0.77,2.25,6.2,3.91,9.67,14,{"id":300,"createTime":301,"updateTime":302,"relativeEntities":303,"slug":304,"properties":305,"entityType":24,"verifyStatus":25,"verifyTime":316,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":234,"subjectFields":317,"manageAffiliations":318,"indexDatabases":388,"url":389,"thumbnailPath":390,"statistic":391,"gsStatistic":409,"type":175,"analyzePriority":26},"a7166325-6c9e-4db3-8a59-7c879701a372","2023-07-31T04:28:49.231+00:00","2026-06-18T23:33:22.428+00:00",[],"VNU-Journal-of-Science-Policy-and-Management-Studies",{"country":306,"issn":307,"eissn":309,"title":311,"gsId":314},{"VOID":15},{"VOID":308},"26159295",{"VOID":310},"25881116",{"EN":312,"VI":313},"VNU Journal of Science: Policy and Management Studies","Tạp chí Nghiên cứu Chính sách và Quản lý",{"VOID":315},"xKW2E_cAAAAJ","2023-08-01T03:23:46.688+00:00",[],[319],{"id":320,"createTime":321,"updateTime":322,"relativeEntities":323,"slug":324,"properties":325,"entityType":98,"verifyStatus":25,"verifyTime":335,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":336,"url":337,"parentIds":338,"statistic":339},"12466116-8f60-4b01-8faf-2411483a0977","2023-05-30T09:37:38.472+00:00","2026-06-19T02:14:28.352+00:00",[],"Vietnam-National-University",{"country":326,"title":327,"abbreviation":330,"address":332},{"VOID":15},{"EN":328,"VI":329},"Vietnam National University, Hanoi","Đại học Quốc gia Hà Nội",{"VOID":331},"VNU",{"VI":333,"EN":334},"Số 144 Xuân Thủy, Phường Dịch Vọng Hậu, Quận Cầu Giấy, Hà Nội, Việt Nam","No. 144 Xuan Thuy Street, Dich Vong Hau Ward, Cau Giay District, Hanoi, Vietnam","2023-08-02T13:58:17.029+00:00",16,"http:\u002F\u002Fwww.vnu.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":340,"i10Index":285,"i10IndexLast5Year":162,"totalPublication":344,"totalPublicationByYear":345,"totalCitation":354,"totalCitationByYear":355,"totalCitationPerPublication":368,"totalCitationPerPublicationByYear":369,"hindexLast5Year":336,"hindex":336},{"2014":109,"2015":231,"2016":231,"2017":206,"2018":341,"2019":110,"2020":342,"2021":343,"2022":171,"2023":231,"2024":110,"2025":39},0.06,0.18,0.35,1247,{"2003":115,"2004":115,"2005":114,"2006":59,"2007":111,"2008":162,"2009":59,"2010":50,"2011":124,"2012":336,"2013":260,"2014":244,"2015":250,"2016":281,"2017":346,"2018":347,"2019":348,"2020":349,"2021":350,"2022":351,"2023":352,"2024":353,"2025":255,"2026":50},94,88,83,67,176,185,187,93,1644,{"2004":111,"2005":115,"2006":52,"2007":298,"2008":356,"2009":298,"2010":286,"2011":357,"2012":244,"2013":358,"2014":359,"2015":360,"2016":361,"2017":362,"2018":363,"2019":364,"2020":365,"2021":366,"2022":367,"2023":367,"2024":162},13,81,48,70,151,115,109,259,174,181,121,101,1.32,{"2004":111,"2005":370,"2006":59,"2007":371,"2008":372,"2009":373,"2010":374,"2011":375,"2012":376,"2013":377,"2014":378,"2015":379,"2016":380,"2017":381,"2018":382,"2019":383,"2020":384,"2021":385,"2022":386,"2023":387,"2024":109},0.5,3.5,2.6,4.67,5.5,4.76,1.81,1.85,2.41,2.29,2.13,1.16,2.94,2.1,2.7,0.69,0.55,0.54,[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FPaM","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002Fa7166325-6c9e-4db3-8a59-7c879701a372\u002Fecfe83f4bcc60c7023ae04d8900fe0ac.jpg",{"impactFactor":36,"impactFactorByYear":392,"i10Index":111,"i10IndexLast5Year":36,"totalPublication":394,"totalPublicationByYear":395,"totalCitation":399,"totalCitationByYear":400,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":403,"hindexLast5Year":158,"hindex":158},{"2018":109,"2019":171,"2020":393,"2021":108,"2022":54,"2023":206,"2024":54},0.23,320,{"2015":50,"2016":239,"2017":286,"2018":396,"2019":397,"2020":159,"2021":398,"2022":168,"2023":79,"2024":255},30,35,40,247,{"2015":115,"2016":242,"2017":401,"2018":222,"2019":402,"2020":79,"2021":239,"2022":50,"2023":116},77,50,{"2015":404,"2016":169,"2017":405,"2018":406,"2019":407,"2020":408,"2021":386,"2022":291,"2023":232},0.12,1.75,0.9,1.43,0.86,{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":103,"totalPublicationByYear":410,"totalCitation":234,"totalCitationByYear":411,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":412,"hindexLast5Year":114,"hindex":59},{"2015":114,"2016":116},{"2016":115,"2017":114,"2018":114,"2019":59,"2020":114,"2021":59,"2022":114,"2023":114,"2024":115,"2026":115},{"2016":108},{"id":414,"createTime":415,"updateTime":416,"relativeEntities":417,"slug":418,"properties":419,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":238,"subjectFields":428,"manageAffiliations":429,"indexDatabases":430,"url":431,"thumbnailPath":26,"statistic":432,"gsStatistic":438,"type":175,"analyzePriority":26},"16e65a3f-d274-47dd-8691-56d76eb58c3d","2023-05-30T09:10:06.062+00:00","2026-06-18T23:33:17.679+00:00",[],"Vietnam-Journal-of-Otorhinolaryngology-Head-and-Neck-Surgery",{"country":420,"issn":421,"title":423,"gsId":426},{"VOID":15},{"VOID":422},"18593704",{"EN":424,"VI":425},"Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery","Tạp chí Tai Mũi Họng Việt Nam",{"VOID":427},"L78B_eIAAAAJ",[],[],[],"https:\u002F\u002Ftapchitaimuihong.vn\u002Findex.php\u002Ftmh",{"impactFactor":36,"impactFactorByYear":433,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":434,"totalPublicationByYear":435,"totalCitation":111,"totalCitationByYear":436,"totalCitationPerPublication":230,"totalCitationPerPublicationByYear":437,"hindexLast5Year":115,"hindex":115},{"2024":229},95,{"2022":52,"2023":286,"2024":255,"2025":53},{"2023":111},{"2023":231},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":240,"totalPublicationByYear":439,"totalCitation":234,"totalCitationByYear":440,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":442,"hindexLast5Year":114,"hindex":114},{"2023":53,"2024":116,"2025":135,"2026":115},{"2024":59,"2025":298,"2026":114},0.68,{"2024":443,"2025":444,"2026":114},0.3,2.33,{"id":446,"createTime":447,"updateTime":448,"relativeEntities":449,"slug":450,"properties":451,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":396,"subjectFields":460,"manageAffiliations":461,"indexDatabases":462,"url":463,"thumbnailPath":464,"statistic":465,"gsStatistic":472,"type":175,"analyzePriority":26},"25988add-c322-4eda-afda-63b1559bb824","2023-04-07T03:49:55.817+00:00","2026-06-18T23:32:23.776+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Y%20-%20D%C6%B0%E1%BB%A3c%20h%E1%BB%8Dc%20qu%C3%A2n%20s%E1%BB%B1",{"country":452,"issn":453,"title":455,"gsId":458},{"VOID":15},{"VOID":454},"18590748",{"EN":456,"VI":457},"Journal of Military Pharmaco-medicine","Tạp chí Y - Dược học quân sự",{"VOID":459},"_pmQ8IEAAAAJ",[],[],[],"https:\u002F\u002Fjmpm.vn\u002Findex.php\u002Fjmpm","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F25988add-c322-4eda-afda-63b1559bb824\u002F09c6bc42157cf5ece95edc971ccddb52.jpg",{"impactFactor":36,"impactFactorByYear":466,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":467,"totalPublicationByYear":468,"totalCitation":135,"totalCitationByYear":470,"totalCitationPerPublication":38,"totalCitationPerPublicationByYear":471,"hindexLast5Year":115,"hindex":115},{"2023":229,"2024":38},475,{"2022":168,"2023":365,"2024":469,"2025":124},236,{"2022":114,"2023":111},{"2022":109,"2023":229},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":277,"totalPublicationByYear":473,"totalCitation":401,"totalCitationByYear":474,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":475,"hindexLast5Year":59,"hindex":59},{"2015":115,"2018":114,"2019":115,"2020":115,"2021":59,"2022":103,"2023":159,"2024":287,"2025":237},{"2020":115,"2021":115,"2022":115,"2023":52,"2024":237,"2025":79,"2026":116},{"2020":115,"2021":476,"2022":171,"2023":477,"2024":478,"2025":479},0.33,0.24,0.7,1.39,{"id":481,"createTime":482,"updateTime":483,"relativeEntities":484,"slug":485,"properties":486,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":496,"translateLanguages":26,"viewCount":45,"subjectFields":497,"manageAffiliations":498,"indexDatabases":525,"url":526,"thumbnailPath":527,"statistic":528,"gsStatistic":26,"type":26,"analyzePriority":26},"2b8d7b12-2d20-4777-be98-077f44f03c69","2023-09-07T07:40:58.286+00:00","2025-07-13T21:21:00.542+00:00",[],"VNU-Journal-of-Social-Sciences-and-Humanities",{"country":487,"issn":488,"introduce":490,"title":493},{"VOID":15},{"VOID":489},"23541172",{"EN":491,"VI":492},"{\"ops\":[{\"insert\":\"VNU Journal of Social Sciences and Humanities (ISSN 2354-1172) is a double-blind peer-reviewed journal published by University of Social Sciences and Humanities, Vietnam National University, Hanoi, Vietnam, under the publication permit no. 155\u002FGP-BTTTT, issued on 11\"},{\"attributes\":{\"script\":\"super\"},\"insert\":\"th \"},{\"insert\":\"May, 2015 by Ministry of Information and Communications. The journal publishes four Vietnamese issues and two English issues per year.\\nCurrently, there are 35 reputable professors in the editorial board. The main objectives of the journal include: providing an intellectual platform for Vietnamese and international scholars; promoting interdisciplinary studies in social sciences and humanities; becoming the leading journal in social sciences and humanities in Vietnam; being indexed by worldwide databases and having academic recognition internationally in the near future.\\nThe journal is currently indexed by Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services and Vietnam National University’s digital archive.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Journal of Social Sciences and Humanities-Vietnam\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"ISSN 2354-1172, email: tapchikhxhnv@gmail.com, tckhxhnv@vnu.edu.vn\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Được thành lập ngày 31\u002F8\u002F2015 (giấy phép hoạt động số 155\u002FGP-BVHTT ngày 11 tháng 5 năm 2015 của Bộ Thông tin và Truyền thông, mã số tiêu chuẩn quốc tế ISSN 2354-1172), Tạp chí Khoa học Xã hội và Nhân văn (Journal of Social Sciences and Humanities) là ấn phẩm khoa học chính thức, duy nhất của Trường Đại học Khoa học Xã hội và Nhân văn, ĐHQG Hà Nội, phát triển và kế thừa Chuyên san Khoa học Xã hội và Nhân văn, Tạp chí Khoa học, ĐHQG Hà Nội.\\nTạp chí xuất bản định kỳ (04 số tiếng Việt\u002Fnăm và 02 số tiếng Anh\u002Fnăm), có nhiệm vụ \"},{\"attributes\":{\"italic\":true},\"insert\":\"công bố, giới thiệu các công trình nghiên cứu khoa học khoa học xã hội và nhân văn của các tác giả là các nhà khoa học trong và ngoài nước, phục vụ giảng dạy, học tập và nghiên cứu khoa học\"},{\"insert\":\". Hội đồng biên tập của Tạp chí hiện bao gồm 33 nhà khoa học có uy tín trong nước và quốc tế. Tạp chí tập trung và ưu tiên đăng tải những bài báo theo định hướng của tinh thần cởi mở, sáng tạo, nhanh chóng vươn lên để tiếp cận và sánh ngang với các tạp chí có uy tín hàng đầu của khu vực và trên thế giới. Nội dung chính của Tạp chí bao gồm các Bài nghiên cứu (khoảng 6000 đến 15000 từ), các bài điểm sách, thông tin khoa học (khoảng 300 đến 1500 từ) được trình bày theo đúng cấu trúc và chuẩn mực của một tạp chí khoa học.\\nCác bài viết của Tạp chí hiện đang được trích dẫn bởi Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services.\\nMọi thông tin xin liên hệ: \"},{\"attributes\":{\"italic\":true},\"insert\":\"Phòng Tạp chí, 701 - E, Trường Đại học Khoa học Xã hội và Nhân văn, 336 Nguyễn Trãi, Thanh Xuân, Hà Nội. ĐT: 024.35581984; email: tckhxhnv@vnu.edu.vn \"},{\"insert\":\"hoặc \"},{\"attributes\":{\"italic\":true},\"insert\":\"tapchikhxhnv@gmail.com \"},{\"insert\":\"\\n\"}]}",{"EN":494,"VI":495},"VNU Journal of Social Sciences and Humanities","Tạp chí Khoa học Xã hội và Nhân văn",[101,102],[],[499],{"id":500,"createTime":501,"updateTime":502,"relativeEntities":503,"slug":504,"properties":505,"entityType":98,"verifyStatus":25,"verifyTime":509,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"url":26,"parentIds":510,"statistic":511},"8b6e349b-0daf-4895-9c3f-85f30f1bfd42","2023-07-31T12:55:58.430+00:00","2026-06-19T02:30:07.899+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Khoa-h%E1%BB%8Dc-X%C3%A3-h%E1%BB%99i-v%C3%A0-Nh%C3%A2n-v%C4%83n-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-H%C3%A0-N%E1%BB%99i",{"title":506},{"EN":507,"VI":508},"VNU University of Social Sciences and Humanities","Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Hà Nội","2023-08-02T15:28:49.057+00:00",[],{"impactFactor":36,"impactFactorByYear":512,"i10Index":59,"i10IndexLast5Year":115,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":518,"totalCitationByYear":519,"totalCitationPerPublication":520,"totalCitationPerPublicationByYear":521,"hindexLast5Year":162,"hindex":162},{"2016":229,"2017":230,"2018":229,"2021":230,"2022":58,"2023":513,"2024":38},0.15,365,{"2013":115,"2014":158,"2015":125,"2016":252,"2017":44,"2018":516,"2019":286,"2020":396,"2021":259,"2022":517,"2023":396,"2024":115,"2025":59,"2026":115},21,42,169,{"2015":283,"2016":135,"2017":52,"2018":50,"2019":298,"2020":53,"2021":359,"2022":115,"2023":115},0.46,{"2015":266,"2016":57,"2017":57,"2018":522,"2019":523,"2020":524,"2021":368,"2022":229,"2023":39},0.38,0.32,0.37,[],"http:\u002F\u002Fjournal.ussh.vnu.edu.vn\u002Findex.php\u002Fvjossh","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F2b8d7b12-2d20-4777-be98-077f44f03c69\u002F0bd0751202944a4b4165b482e6e623e4.png",{"impactFactor":36,"impactFactorByYear":529,"i10Index":162,"i10IndexLast5Year":115,"totalPublication":530,"totalPublicationByYear":531,"totalCitation":537,"totalCitationByYear":538,"totalCitationPerPublication":343,"totalCitationPerPublicationByYear":540,"hindexLast5Year":135,"hindex":135},{"2016":341,"2017":39,"2018":229,"2019":38,"2020":110,"2021":231,"2022":231,"2023":341,"2024":39},764,{"2015":255,"2016":245,"2017":532,"2018":259,"2019":533,"2020":534,"2021":535,"2022":536,"2023":534,"2024":254,"2025":50},111,106,68,92,89,265,{"2015":539,"2016":241,"2017":168,"2018":51,"2019":349,"2020":260,"2021":244,"2022":298,"2023":114},46,{"2015":541,"2016":523,"2017":524,"2018":290,"2019":542,"2020":522,"2021":523,"2022":57,"2023":39},1.48,0.63,{"id":544,"createTime":545,"updateTime":546,"relativeEntities":547,"slug":548,"properties":549,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":558,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":50,"subjectFields":559,"manageAffiliations":560,"indexDatabases":561,"url":562,"thumbnailPath":563,"statistic":564,"gsStatistic":26,"type":26,"analyzePriority":26},"6ec01bd0-15c0-469a-86ac-41339076ae0a","2023-08-10T07:08:33.153+00:00","2026-01-31T21:19:06.362+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Da-li%E1%BB%85u-h%E1%BB%8Dc-Vi%E1%BB%87t-Nam",{"country":550,"issn":551,"introduce":553,"title":555},{"VOID":15},{"VOID":552},"18594824",{"VI":554},"{\"ops\":[{\"insert\":\"Tạp chí “Da liễu học Việt Nam” (Tiếng Anh: Vietnamese Journal of Dermatology and Venereology) thuộc Hội Da liễu Việt Nam, xuất bản 4 số mỗi năm bằng tiếng Việt hoặc tiếng Anh.\\nTạp chí Da liễu học Việt Nam hoạt động với mục đích, tôn chỉ là phổ biến, trao đổi thông tin trong lĩnh vực chuyên ngành da liễu; đăng tải các công trình nghiên cứu khoa học; chuyển giao công nghệ - kinh tế và khoa học kỹ thuật liên quan đến lĩnh vực da liễu.\\nPhạm vi của tạp chí là tất cả các bài báo khoa học, bài tổng quan, giới thiệu ca lâm sàng, … có liên quan tới chuyên ngành da liễu trong và ngoài nước. Tạp chí công bố các công trình nghiên cứu liên quan đến mô hình bệnh tật, các phương pháp chẩn đoán, điều trị, dự phòng và phục hồi chức năng các bệnh thuộc chuyên ngành da liễu. Ngoài ra, tạp chí còn đăng tải các bài tổng quan, cập nhật thông tin, kiến thức, hướng dẫn chẩn đoán, điều trị trong chuyên ngành da liễu trong nước và quốc tế; đăng tải các bài ca lâm sàng đặc biệt trong chuyên ngành da liễu.\\nTạp chí Da liễu học Việt Nam được biết tới là một tạp chí chuyên ngành có uy tín trong lĩnh vực da liễu. Các bài báo về nghiên cứu khoa học đăng trong Tạp chí được bình duyệt một cách nghiêm ngặt bởi ít nhất 2 chuyên gia. Hội đồng biên tập tạp chí bao gồm các nhà khoa học có uy tín (Giáo sư, Phó Giáo sư, Tiến sĩ, Bác sĩ…) trong chuyên ngành da liễu nhằm đảm bảo chất lượng và tính khách quan, khoa học cho các bài viết đăng trên Tạp chí.\\n\"}]}",{"EN":556,"VI":557},"Vietnamese Journal of Dermatology and Venereology","Tạp chí Da liễu học Việt Nam","Admin Import",[],[],[],"https:\u002F\u002Fvjdv.vn\u002Findex.php\u002Fvjdv","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6ec01bd0-15c0-469a-86ac-41339076ae0a\u002F3cbc81720e58429dc7b1c4d7ab1935ca.jpg",{"impactFactor":36,"impactFactorByYear":565,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":566,"totalPublicationByYear":567,"totalCitation":116,"totalCitationByYear":570,"totalCitationPerPublication":109,"totalCitationPerPublicationByYear":571,"hindexLast5Year":115,"hindex":115},{"2023":38,"2024":230},182,{"2022":568,"2023":45,"2024":569},69,56,{"2022":52,"2023":115},{"2022":40,"2023":229},{"id":573,"createTime":574,"updateTime":575,"relativeEntities":576,"slug":577,"properties":578,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":587,"translateLanguages":26,"viewCount":283,"subjectFields":588,"manageAffiliations":589,"indexDatabases":647,"url":648,"thumbnailPath":649,"statistic":650,"gsStatistic":26,"type":26,"analyzePriority":26},"19221551-7519-47ff-a892-331d1139c64b","2023-09-12T07:03:05.744+00:00","2026-01-24T20:54:40.144+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-S%E1%BB%A9c-kho%E1%BA%BB-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":579,"issn":580,"introduce":582,"title":584},{"VOID":15},{"VOID":581},"27349446",{"EN":583},"{\"ops\":[{\"attributes\":{\"bold\":true},\"insert\":\"1. History\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Science and Technology Development Journal\"},{\"insert\":\" (STDJ) (ISSN 2734-9446), Vietnam National University - Ho Chi Minh City (VNU-HCM) was established in 1997. And the first issue was published in January 1998 with ISSN 1859-0128. Since then, STDJ has become the most important scientific forum of scientists from VNU-HCM as well as other universities. The magazine has undergone 20 years of development and has become a bridge for scientific exchanges, as well as enriching reference materials for the faculty, doctoral students, students of VNU-HCM in particular and other universities, institutes...\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal since 2020.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\" \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"2. Focus and Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":585,"VI":586},"VNUHCM JOURNAL OF HEALTH SCIENCES","Tạp chí Khoa học Sức khoẻ Đại học Quốc gia Thành phố Hồ Chí Minh",[101,102],[],[590],{"id":591,"createTime":592,"updateTime":593,"relativeEntities":594,"slug":595,"properties":596,"entityType":98,"verifyStatus":25,"verifyTime":606,"verifyNote":26,"syncStatus":28,"languages":607,"translateLanguages":26,"viewCount":608,"url":609,"parentIds":610,"statistic":611},"fc4c2560-868c-4677-acb1-8686bef88727","2023-06-26T04:48:23.774+00:00","2026-06-19T01:46:17.248+00:00",[],"%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":597,"title":598,"abbreviation":601,"address":603},{"VOID":15},{"EN":599,"VI":600},"Vietnam National University Ho Chi Minh City","Đại học Quốc gia Thành phố Hồ Chí Minh",{"VOID":602},"VNUHCM",{"VI":604,"EN":605},"khu phố 6, Phường Linh Trung, Thành phố Thủ Đức, Thành phố Hồ Chí Minh, Việt Nam","Quarter 6, Linh Trung Ward, Thu Duc City, Ho Chi Minh City, Vietnam","2023-08-16T14:13:07.134+00:00",[101,102],45,"https:\u002F\u002Fvnuhcm.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":612,"i10Index":285,"i10IndexLast5Year":51,"totalPublication":613,"totalPublicationByYear":614,"totalCitation":624,"totalCitationByYear":625,"totalCitationPerPublication":634,"totalCitationPerPublicationByYear":635,"hindexLast5Year":124,"hindex":124},{"2014":36,"2015":38,"2016":109,"2017":39,"2018":229,"2019":38,"2020":110,"2021":171,"2022":110,"2023":110,"2024":171,"2025":229},3708,{"2005":115,"2006":115,"2007":115,"2008":135,"2009":111,"2010":53,"2011":52,"2012":568,"2013":615,"2014":351,"2015":616,"2016":469,"2017":617,"2018":127,"2019":618,"2020":619,"2021":620,"2022":621,"2023":622,"2024":623,"2025":159,"2026":50},164,266,177,226,603,931,314,246,74,2399,{"2006":115,"2008":50,"2010":162,"2011":242,"2012":222,"2013":43,"2014":626,"2015":627,"2016":628,"2017":629,"2018":258,"2019":630,"2020":631,"2021":632,"2022":633,"2023":353,"2024":115},250,124,157,162,152,385,559,128,0.65,{"2006":115,"2008":636,"2010":637,"2011":638,"2012":639,"2013":522,"2014":640,"2015":641,"2016":642,"2017":643,"2018":644,"2019":642,"2020":645,"2021":292,"2022":646,"2023":522,"2024":38},1.33,0.45,2.22,0.39,1.35,0.47,0.67,0.92,0.73,0.64,0.41,[],"http:\u002F\u002Fstdjhs.scienceandtechnology.com.vn\u002Findex.php\u002Fstdjhs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F19221551-7519-47ff-a892-331d1139c64b\u002F2e10768b7d1e380c36a25ed0c714dd7e.png",{"impactFactor":36,"impactFactorByYear":651,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":652,"totalPublicationByYear":653,"totalCitation":516,"totalCitationByYear":654,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":655,"hindexLast5Year":59,"hindex":59},{"2022":57,"2023":108,"2024":39},79,{"2020":116,"2021":240,"2022":239,"2023":52,"2024":162,"2025":162},{"2020":59,"2021":51,"2022":59},{"2020":443,"2021":387,"2022":54},{"code":657,"data":658,"meta":26},"SUCCESS",{"id":659,"createTime":660,"updateTime":660,"relativeEntities":661,"slug":662,"properties":663,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":668,"manageAffiliations":669,"indexDatabases":670,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},"83289c5a-0e1a-4089-90d0-8447ef02c8ba","2023-12-05T06:03:54.978+00:00",[],"EMC-Ginecolog%C3%ADa-Obstetricia",{"issn":664,"title":666},{"VOID":665},"1283081X",{"EN":667},"EMC - Ginecología-Obstetricia",[],[],[],{"meta":672,"data":674},{"total":673},"233",[675,773,868,936,1212,1286,1392,1462,1539,1583],{"id":676,"createTime":677,"updateTime":678,"relativeEntities":679,"slug":680,"properties":681,"entityType":688,"verifyStatus":25,"verifyTime":689,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":691,"fullTextUrl":26,"authors":692,"publicationType":747,"publisherRelationship":748,"citationCount":36,"citationInfo":762,"publishDate":764,"publishYear":765,"citationAnalyzeStatus":766,"lastCitationAnalyze":767,"indexDatabases":26,"openAccess":26,"references":768,"isForceReanalyzing":772},"2e0022d8-691d-47c1-805b-2646aae83a4e","2024-01-24T08:55:54.986+00:00","2026-06-10T12:40:31.574+00:00",[],"Tratamiento-de-la-f%C3%ADstula-rectovaginal-y-de-las-secuelas-obst%C3%A9tricas",{"title":682,"doi":684,"gsPaper":686},{"ES":683},"Tratamiento de la fístula rectovaginal y de las secuelas obstétricas",{"VOID":685},"10.1016\u002Fs1283-081x(20)43720-8",{"VOID":687},"[\"8941905162942479020\"]","PUBLICATION","2024-05-03T00:37:56.136+00:00","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20437208",[693,709,721,733],{"id":694,"sortIndex":59,"researcher":26,"roles":695,"affiliations":697,"properties":706},"39888c05-cf30-4eaf-ab45-faf3ce88e0b8",[696],"AUTHOR",[698],{"id":26,"sortIndex":36,"affiliation":699,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":702,"slug":26,"properties":703,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d4d18b5e-933d-4c7a-8252-f956d23d19a2","2024-01-24T08:55:55.012+00:00",[],{"title":704},{"VI":705},"Service de chirurgie gynécologique, Hôpital Jeanne-de-Flandre, CHU de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France",{"title":707},{"VI":708},"S. Delplanque",{"id":710,"sortIndex":114,"researcher":26,"roles":711,"affiliations":712,"properties":718},"a42857fa-931d-4443-b6a7-eeb4d3d287d4",[696],[713],{"id":26,"sortIndex":36,"affiliation":714,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":715,"slug":26,"properties":716,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":717},{"VI":705},{"title":719},{"VI":720},"E. Declas",{"id":722,"sortIndex":115,"researcher":26,"roles":723,"affiliations":724,"properties":730},"cf770415-864d-4750-a611-abe739471221",[696],[725],{"id":26,"sortIndex":36,"affiliation":726,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":727,"slug":26,"properties":728,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":729},{"VI":705},{"title":731},{"VI":732},"G. Giraudet",{"id":734,"sortIndex":36,"researcher":26,"roles":735,"affiliations":736,"properties":742},"08fc2047-379d-421d-a1db-869f3b3936fd",[696],[737],{"id":26,"sortIndex":36,"affiliation":738,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":739,"slug":26,"properties":740,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":741},{"VI":705},{"title":743,"gsAuthor":745},{"VI":744},"M. Cosson",{"VOID":746},"[\"mra9H5MAAAAJ\"]","ARTICLE",{"url":691,"publisher":749,"properties":757},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":750,"slug":662,"properties":751,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":754,"manageAffiliations":755,"indexDatabases":756,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":752,"title":753},{"VOID":665},{"EN":667},[],[],[],{"volume":758,"pages":760},{"VOID":759},"56",{"VOID":761},"1-12",{"total":36,"publishYear":36,"statisticByYear":763},{},"2020-05-01",2020,"ERROR_IN_ANALYZE_CITATION","2026-06-10T12:40:31.573+00:00",[769],{"id":26,"text":770,"url":26,"identifiers":771},"Cosson, 2011",{},false,{"id":774,"createTime":775,"updateTime":776,"relativeEntities":777,"slug":778,"properties":779,"entityType":688,"verifyStatus":25,"verifyTime":776,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":786,"fullTextUrl":26,"authors":787,"publicationType":747,"publisherRelationship":854,"citationCount":26,"citationInfo":26,"publishDate":867,"publishYear":765,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"ae90fcaa-5b47-44a7-8ecb-e4c0580df982","2024-01-16T22:01:37.077+00:00","2024-12-24T17:45:08.683+00:00",[],"Presentaciones-en-extensi%C3%B3n",{"references":780,"title":782,"doi":784},{"VOID":781},"Audra P, Thoulon JM, Balsan M. Présentation de la face. EMC (Elsevier Masson SAS, Paris), Obstétrique, 5-049-L-20, 1997.\nBourgeois L. Observations diverses sur la stérilité, perte de fruict, fœcondité, accouchements et maladies des femmes et des enfants nouveaux-nés. 1609.\nMauriceau F. Traité des maladies des femmes grosses 1668. https:\u002F\u002Fgallica.bnf.fr\u002Fark:\u002F12148\u002Fbpt6k553 texteImage. 2783\nBaudelocque JL. Principes de l’art des accouchements. 1787.\nDe La Chapelle ML. Pratique des accouchements. 1821-1825.\nDumont, 1962, Les présentations de la face, Gynecol Obstet, 61, 684\nZayed, 2008, Face and brow presentation in northern Jordan, over a decade of experience, Arch Gynecol Obstet, 278, 427, 10.1007\u002Fs00404-008-0600-0\nTapisiz, 2014, Face presentation at term: a forgotten issue, J Obstet Gynaecol Res, 40, 1573, 10.1111\u002Fjog.12369\nCruishank, 1981, Face and brow presentation, a review, Clin Obstet Gynecol, 24, 333, 10.1097\u002F00003081-198106000-00003\nDucarme, 2006, Présentation de la face : étude rétrospective de 32 cas à terme, Gynecol Obstet Fertil, 34, 393, 10.1016\u002Fj.gyobfe.2005.07.042\nWestgren, 1984, Face presentation in modern obstetrics – A study with special reference to fetal long term morbidity, Z Geburtshilfe Perinatol, 188, 87\nBalsan M. La présentation de la face à propos de 24 observations. Besançon, 1994.\nQuiel, 1991, Gesichtslagengeburten, Zentralbl Gynakol, 113, 1380\nThoulon, 1971, La présentation de la face, Rev Fr Gynecol Obstet, 66, 231\nChaoui, 1982, La présentation de la face, J Gynecol Obstet Biol Reprod, 11, 731\nBenedetti, 1980, Face presentation at term, Obstet Gynecol, 55, 199\nDuff, 1981, Diagnosis and management of face presentation, Obstet Gynecol, 57, 105\nAudra, 1988, Les présentations céphaliques défléchies. À propos de 80 observations, Rev Fr Gynecol Obstet, 83, 355\nShaffer, 2006, Face presentation: predictors and delivery route, Am J Obstet Gynecol, 194, e10, 10.1016\u002Fj.ajog.2005.11.029\nBhal, 1998, A population study of face and brow presentation, J Obstet Gynaecol, 18, 231, 10.1080\u002F01443619867371\nDumont, 1968, Les présentations du front (étude de 29 observations et comparaisons de deux séries de cas recueillis entre 1949-1954 et 1955-1966), Rev Fr Gynecol Obstet, 63, 225\nEijskoot, 1977, An ultrasonic device for continuous measurement of cervical dilation during labor, Ultrasonics, 15, 183, 10.1016\u002F0041-624X(77)90052-X\nFloberg, 1987, Influence of the pelvic outlet capacity on fetal head presentation at delivery, Acta Obstet Gynecol Scand, 66, 127, 10.3109\u002F00016348709083033\nMostar, 1966, Deflexion attitudes Median vertex persistent, brow, and face presentations, Obstet Gynecol, 28, 49\nPosner, 1943, Face and persistant brow presentation, Surg Gynecol Obstet, 77, 618\nPosner, 1975, Modern trends in the management of face and brow presentation, Surg Gynecol Obstet, 104, 485\nReddoch, 1948, Face presentation, Am J Obstet Gynecol, 56, 86, 10.1016\u002F0002-9378(48)90192-6\nPrevedourakis, 1966, Face presentation. An analysis of 163 cases, Am J Obstet Gynecol, 94, 1092, 10.1016\u002F0002-9378(66)90770-8\nRudolph, 1947, Face presentation, Am J Obstet Gynecol, 54, 987, 10.1016\u002FS0002-9378(16)39712-5\nJacobson, 1962, Brow face presentations, Am J Obstet Gynecol, 84, 1881, 10.1016\u002F0002-9378(62)90478-7\nMorris, 1953, Face brow presentations, J Obstet Gynaecol Br Emp, 60, 44, 10.1111\u002Fj.1471-0528.1953.tb06410.x\nArsene, 2016, Prenatal factors related to face presentation: a case-control study, Arch Gynecol Obstet, 294, 279, 10.1007\u002Fs00404-015-3992-7\nHellman, 1950, Face and brow presentations, Am J Obstet Gynecol, 59, 831, 10.1016\u002F0002-9378(50)90113-X\nFloberg, 1987, Influence of pelvic outlet capacity on labor. A prospective pelvimetry study of 1,429 unselected primiparas, Acta Obstet Gynecol Scand, 66, 121, 10.3109\u002F00016348709083032\nDede, 1963, Face presentation, Am J Obstet Gynecol, 87, 515, 10.1016\u002F0002-9378(63)90563-5\nIngoldsson, 1969, Brow presentation, Acta Obstet Gynecol Scand, 48, 486, 10.3109\u002F00016346909156664\nMandoul, 1983, Diagnostic anténatal d’une tumeur du cou par échographie, JEMU, 4, 155\nRuf, 1962, Déflexion primitive de la tête, Bull Fed Gynecol Obstet, 14, 171\nBorell, 1960, The mecanism of labour in face and brow presentation a radiologic study, Acta Obstet Gynecol Scand, 39, 626, 10.3109\u002F00016346009155741\nLau, 2009, Intrapartum translabial ultrasound demonstrating brow presentation during the second stage of labor, Int J Gynaecol Obstet, 107, 62, 10.1016\u002Fj.ijgo.2009.05.024\nNeuman, 1994, Intrapartum bimanual tocolytic-assisted reversal of face presentation: Preliminary report, Obstet Gynecol, 84, 146\nWhitacre, 1965, Forceps management of breech and face presentations, Clin Obstet Gynecol, 8, 882, 10.1097\u002F00003081-196512000-00007\nOffringa, 2019, Spatulas for entrapment of the after-coming head during vaginal breech delivery, Arch Gynecol Obstet, 299, 1283, 10.1007\u002Fs00404-019-05115-x\nDe Bernardo, 2017, Face presentation in delivery room: what is strategy?, BMJ Case Rep, 2017\nÖzdemir, 2018, Lip and face edema due to face presentation, J Pediatr Res, 5, 52, 10.4274\u002Fjpr.63626\nAudra, 1988, Monitoring of pregnancy and delivery in women over 40, Soins Gynecol Obstet Pueric Pediatr, 18\nThoulon, 1971, Transformation spontanée d’une attitude défléchie (front primitif en sommet dans les derniers mois de la grossesse), Bull Fed Gynecol Obstet, 23, 620\nLuker, 2005, Vaginal delivery of two cases of brow presentation using multiple Kiwi Omnicups, J Obstet Gynaecol, 25, 601, 10.1080\u002F01443610500242309\nHakmi, 2008, Brow presentation does not mean caesarean section, J Obstet Gynaecol, 28, 255, 10.1080\u002F01443610801976050\nGernez, 1978, La présentation du bregma, cette méconnue, Rev Fr Gynecol Obstet, 73, 757\nThoulon JM, Welfen-Ekra C, Arnould P, Audra P. Étude anatomoclinique et radiologique du bassin obstétrical. EMC (Elsevier Masson SAS, Paris), Obstétrique, 5-007-A-10, 1997.",{"ES":783},"Presentaciones en extensión",{"VOID":785},"10.1016\u002Fs1283-081x(20)43356-9","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20433569",[788,803,818,830,842],{"id":789,"sortIndex":36,"researcher":26,"roles":790,"affiliations":791,"properties":800},"52b241a3-05f1-4e9f-b327-9576935c6f7f",[696],[792],{"id":26,"sortIndex":36,"affiliation":793,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":796,"slug":26,"properties":797,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"6272e170-9888-4f00-8df9-3ed420a10323","2024-01-16T22:01:37.100+00:00",[],{"title":798},{"VI":799},"Service de gynécologie-obstétrique, CHU de Grenoble-Alpes, avenue Maquis-du-Grésivaudan, 38700 La Tronche, France",{"title":801},{"VI":802},"D. Riethmuller",{"id":804,"sortIndex":114,"researcher":26,"roles":805,"affiliations":806,"properties":815},"404b4d19-6964-41b3-95b0-d366e21d1f3a",[696],[807],{"id":26,"sortIndex":36,"affiliation":808,"properties":26},{"id":809,"createTime":810,"updateTime":810,"relativeEntities":811,"slug":26,"properties":812,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"b408642c-87d7-462f-8f83-9992d6839849","2024-01-16T22:01:37.142+00:00",[],{"title":813},{"VI":814},"Pôle Mère-Femme, CHU de Besançon, Besançon, France",{"title":816},{"VI":817},"R. Ramanah",{"id":819,"sortIndex":111,"researcher":26,"roles":820,"affiliations":821,"properties":827},"3ce2cfb4-2d19-4ffa-b07b-2956c4d99f99",[696],[822],{"id":26,"sortIndex":36,"affiliation":823,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":824,"slug":26,"properties":825,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":826},{"VI":799},{"title":828},{"VI":829},"V. Equy",{"id":831,"sortIndex":59,"researcher":26,"roles":832,"affiliations":833,"properties":839},"ecd3b28a-08e8-4bc3-95ca-40ff9c4eacb7",[696],[834],{"id":26,"sortIndex":36,"affiliation":835,"properties":26},{"id":809,"createTime":810,"updateTime":810,"relativeEntities":836,"slug":26,"properties":837,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":838},{"VI":814},{"title":840},{"VI":841},"L. Courtois",{"id":843,"sortIndex":115,"researcher":26,"roles":844,"affiliations":845,"properties":851},"8cb19c6a-9336-4882-a326-5e4431f596c9",[696],[846],{"id":26,"sortIndex":36,"affiliation":847,"properties":26},{"id":809,"createTime":810,"updateTime":810,"relativeEntities":848,"slug":26,"properties":849,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":850},{"VI":814},{"title":852},{"VI":853},"N. Mottet",{"url":786,"publisher":855,"properties":863},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":856,"slug":662,"properties":857,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":860,"manageAffiliations":861,"indexDatabases":862,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":858,"title":859},{"VOID":665},{"EN":667},[],[],[],{"volume":864,"pages":865},{"VOID":759},{"VOID":866},"1-13","2020-03-01",{"id":869,"createTime":870,"updateTime":870,"relativeEntities":871,"slug":26,"properties":872,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":879,"fullTextUrl":26,"authors":880,"publicationType":747,"publisherRelationship":920,"citationCount":26,"citationInfo":26,"publishDate":934,"publishYear":935,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"e4ac5b66-eae3-4d43-bc88-c34a1ef5d73a","2023-12-12T03:53:07.952+00:00",[],{"references":873,"title":875,"doi":877},{"VOID":874},"Ibanez, 2000, Premature adrenarche: normal variant or forerunner of adult disease?, Endocr. Rev., 21, 671, 10.1210\u002Fer.21.6.671\nApter, 1993, Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins, J. Clin. Endocrinol. Metab., 76, 940, 10.1210\u002Fjc.76.4.940\nIbanez, 1998, Possible genesis of polycystic ovary syndrom in the periadolescent girl, Curr. Opin. Endocrinol Diab, 5, 19, 10.1097\u002F00060793-199802000-00004\nvan Hooff, 2004, Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years, Hum. Reprod., 19, 383, 10.1093\u002Fhumrep\u002Fdeh079\nLobo, 1991, Ovarian hyperandrogenism and androgen producing tumors, Endocrinol. Metab. Clin. North Am., 20, 773, 10.1016\u002FS0889-8529(18)30244-5\nYoung, 1985, Ovarian Sertoli-Leydig cell tumors: a clinicopathological analysis of 207 cases, Am. J. Surg. Pathol., 9, 543, 10.1097\u002F00000478-198508000-00001\nCaron, 1993, Androgenic granulosa cell tumor of the ovary: in vivo hormonal studies, J. Endocrinol. Invest., 16, 545, 10.1007\u002FBF03348903\nAbbott, 2002, Developmental origin of polycystic ovary syndrome-a hypothesis, J. Endocrinol., 174, 1, 10.1677\u002Fjoe.0.1740001\nStrauss, 1999, Molecular mysteries of polycystic ovary syndrome, Mol. Endocrinol., 13, 800, 10.1210\u002Fme.13.6.800\nDunaif, 1997, Insulin resistance and the polycystic ovarian syndrome: mechanism and implications for pathogenesis, Endocr. Rev., 18, 774, 10.1210\u002Fer.18.6.774\nWebber, 2003, Formation and early development of follicles in the polycystic ovary, Lancet, 362, 1017, 10.1016\u002FS0140-6736(03)14410-8\nDewailly, 1997, Definition, clinical manifestations, and prevalance of PCOS, 259\nZacur, 1997, Prolactin abnormalities in PCOS, 287\n2004, The Rotterdam ESHRE\u002FASRM sponsored PCOS consensus workshop group, Hum. Reprod., 19, 41\nBalen, 2003, Ultrasound assessment of the polycystic ovary: international consensus definitions, Hum. Reprod. Update, 9, 505, 10.1093\u002Fhumupd\u002Fdmg044\nForest, 1992, Formes non classiques dites « tardives » du déficit en 21-hydroxylase : diagnostic différentiel avec les hétérozygotes et conseil génétique, Rev. Fr. Endocrinol. Clin., 33, 47\nDewailly, 1997, Pathophysiology and clinical manifestations of nonclassic 21-hydroxylase deficiency, 173\nAzziz, 1997, Idiopathic Hirsutism: definition, prevalence and inheritance, 529\nCortet-Rudelli, 1997, Drug-induced androgen excess, 613\nNelson-DeGrave, 2004, Valproate potentiates androgen biosynthesis in human ovarien theca cells, Endocrinology, 145, 799, 10.1210\u002Fen.2003-0940\nDiamanti-Kandarakis, 1997, Cushing's disease and androgen excess, 569\nDeroubaix-Allard, 1997, Acromegaly and androgen excess, 585\nAzziz, 1997, Diagnosis, screening, and treatment of nonclassic 21-hydroxylase deficiency, 181\nSpritzer, 1990, Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia, J. Clin. Endocrinol. Metab., 70, 642, 10.1210\u002Fjcem-70-3-642\nIbanez, 2004, Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide, J. Clin. Endocrinol. Metab., 89, 4716, 10.1210\u002Fjc.2004-0047\nKorytkowski, 1995, Metabolic effects of oral contraceptives in women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 80, 3327, 10.1210\u002Fjc.80.11.3327",{"ES":876},"Hiperandrogenismo en la adolescente",{"VOID":878},"10.1016\u002Fs1283-081x(06)46492-4","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X06464924",[881,896,908],{"id":882,"sortIndex":114,"researcher":26,"roles":883,"affiliations":884,"properties":893},"6cfd7a71-c611-4f3f-bcf0-f2ea5b695550",[696],[885],{"id":26,"sortIndex":36,"affiliation":886,"properties":26},{"id":887,"createTime":888,"updateTime":888,"relativeEntities":889,"slug":26,"properties":890,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"38c841f4-3384-42fa-b581-8e6f69a378a8","2023-12-12T03:53:07.978+00:00",[],{"title":891},{"VI":892},"Service de gynécologie endocrinienne et de médecine de la reproduction, centre hospitalier universitaire de Lille, hôpital Jeanne de Flandre, 2, avenue Oscar-Lambert, 59037 Lille cedex, France",{"title":894},{"VI":895},"D. Dewailly",{"id":897,"sortIndex":115,"researcher":26,"roles":898,"affiliations":899,"properties":905},"5c0b4907-873d-4c44-a4b3-b27503c92a1e",[696],[900],{"id":26,"sortIndex":36,"affiliation":901,"properties":26},{"id":887,"createTime":888,"updateTime":888,"relativeEntities":902,"slug":26,"properties":903,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":904},{"VI":892},{"title":906},{"VI":907},"S. Jonard",{"id":909,"sortIndex":36,"researcher":26,"roles":910,"affiliations":911,"properties":917},"200596ea-d35a-46a9-a3c0-ff3aea2f23d5",[696],[912],{"id":26,"sortIndex":36,"affiliation":913,"properties":26},{"id":887,"createTime":888,"updateTime":888,"relativeEntities":914,"slug":26,"properties":915,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":916},{"VI":892},{"title":918},{"VI":919},"C. Richard",{"url":879,"publisher":921,"properties":929},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":922,"slug":662,"properties":923,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":926,"manageAffiliations":927,"indexDatabases":928,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":924,"title":925},{"VOID":665},{"EN":667},[],[],[],{"volume":930,"pages":932},{"VOID":931},"42",{"VOID":933},"1-8","2006-01-01",2006,{"id":937,"createTime":938,"updateTime":938,"relativeEntities":939,"slug":940,"properties":941,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":947,"fullTextUrl":26,"authors":948,"publicationType":747,"publisherRelationship":1197,"citationCount":26,"citationInfo":26,"publishDate":1210,"publishYear":1211,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"1517de81-de0e-4173-bcb4-5f01d1d3395b","2023-12-02T12:30:19.789+00:00",[],"Menopausia",{"references":942,"title":944,"doi":945},{"VOID":943},"Rousset-Jablonski, 2021, How to diagnose menopause? Postmenopausal women management : CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 318\nHarlow, 2007, Recommendations from a multi-study evaluation of proposed criteria for staging reproductive aging, Climacteric, 10, 112, 10.1080\u002F13697130701258838\nRandolph, 2003, Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status, J Clin Endocrinol Metab, 88, 1516, 10.1210\u002Fjc.2002-020777\nRandolph, 2011, Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period, J Clin Endocrinol Metab, 96, 746, 10.1210\u002Fjc.2010-1746\nFreeman, 2007, Association of anti-mullerian hormone levels with obesity in late reproductive-age women, Fertil Steril, 87, 101, 10.1016\u002Fj.fertnstert.2006.05.074\nGracia, 2005, The relationship between obesity and race on inhibin B during the menopause transition, Menopause, 12, 559, 10.1097\u002F01.gme.0000172268.24949.94\nHuddleston, 2010, Racial and ethnic disparities in reproductive endocrinology and infertility, Am J Obstet Gynecol, 202, 413, 10.1016\u002Fj.ajog.2009.12.020\nMaitrot-Mantelet, 2021, Differential diagnosis of vasomotor symptoms. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 329\nPalacios, 2015, Update on management of genitourinary syndrome of menopause: a practical guide, Maturitas, 82, 308, 10.1016\u002Fj.maturitas.2015.07.020\nFaubion, 2017, Genitourinary syndrome of menopause: management strategies for the clinician, Mayo Clin Proc, 92, 1842, 10.1016\u002Fj.mayocp.2017.08.019\nPortman, 2014, Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society, Menopause, 21, 1063, 10.1097\u002FGME.0000000000000329\nNappi, 2016, Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE survey, Climacteric, 19, 188, 10.3109\u002F13697137.2015.1107039\nLegendre, 2012, Urinary incontinence and menopause, Progr Urol, 22, 615, 10.1016\u002Fj.purol.2012.08.267\nGosset, 2021, Menopausal hormone therapy for the management of osteoporosis, Best Pract Res Clin Endocrinol Metab, 35, 10.1016\u002Fj.beem.2021.101551\nGrange L, Chales G, Alliot Launois F. Livre blanc des états généraux de l’ostéoporose 2016.\nPouillès, 2021, Menopause, menopause hormone therapy and osteoporosis. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 420\nBoulat, 2019, Principales évolutions de la mortalité par cause médicale sur la période 2000–2016 en France métropolitaine, Bull Epidemiol Hebd, 576\nLecoffre, 2017, L’accident vasculaire cérébral en France : patients hospitalisés pour AVC en 2014 et évolutions 2008–2014, Bull Epidemiol Hebd, 84\nGabet, 2016, Évolution temporelle du recours à la réadaptation cardiaque après un infarctus du myocarde, France, 2010–2014, Bull Epidemiol Hebd, 43, 764\nPlu-Bureau, 2021, Menopausal hormone therapy an cardiovascular risk. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 438\nHaute Autorité de santé. Cancer du sein : modalités de dépistage en fonction du risque 2014. www.has-sante.fr\u002Fjcms\u002Fpprd_2974673\u002Ffr\u002Fcancer-du-sein-modalites-specifiques-de-depistage-pour-les-femmes-a-haut-risque#toc_1_1_3.\nDuclos, 2021, Effects of physical activity and decreased sedentary behaviours in menopausal women. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 335\nLaCroix, 2017, The objective physical activity and cardiovascular disease health in older women (OPACH) study, BMC Public Health, 17, 192, 10.1186\u002Fs12889-017-4065-6\nAgence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail. Actualisation des repères du PNNS-révision des repères relatifs à l’activité physique et à la sédentarité; 2016.\nInstitut national de la santé et de la recherche médicale. Activité physique : prévention et traitement des maladies chroniques 2019.\nAmbikairajah, 2019, Fat mass changes during menopause: a meta-analysis, Am J Obstet Gynecol, 221, 393, 10.1016\u002Fj.ajog.2019.04.023\nHaute Autorité de santé. Guide de promotion, consultation et prescription médicale d’activité physique et sportive pour la santé chez les adultes 2018. www.has-sante.fr.\nLecerf, 2021, Nutritional advices for postmenopausal woman. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 349\nZiel, 1975, Increased risk of endometrial carcinoma among users of conjugated estrogens, N Engl J Med, 293, 1167, 10.1056\u002FNEJM197512042932303\nGrady, 1992, Hormone therapy to prevent disease and prolong life in postmenopausal women, Ann Intern Med, 117, 1016, 10.7326\u002F0003-4819-117-12-1016\nHulley, 1998, Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\u002Fprogestin Replacement Study (HERS) Research Group, JAMA, 280, 605, 10.1001\u002Fjama.280.7.605\nRossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001\u002Fjama.288.3.321\nChlebowski, 2003, Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial, JAMA, 289, 3243, 10.1001\u002Fjama.289.24.3243\nBeral, 2019, Menopausal hormone therapy and 20-year breast cancer mortality, Lancet, 394, 1139, 10.1016\u002FS0140-6736(19)32033-1\nManson, 2013, Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials, JAMA, 310, 1353, 10.1001\u002Fjama.2013.278040\nManson, 2017, Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women's Health Initiative randomized trials, JAMA, 318, 927, 10.1001\u002Fjama.2017.11217\nBenkhadra, 2015, Menopausal hormone therapy and mortality: a systematic review and meta-analysis, J Clin Endocrinol Metab, 100, 4021, 10.1210\u002Fjc.2015-2238\nHa-Vinh, 2010, Individual factors and mortality associated with hormone replacement therapy in a French cohort of women from 60 to 69 years of age, J Gynecol Obstet Biol Reprod (Paris), 39, 453, 10.1016\u002Fj.jgyn.2010.06.006\nBoardman HM, Hartley L, Eisinga A, Main C, Figuls MR i, Cosp XB, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2015;3:CD002229. Doi: 10.1002\u002F14651858.CD002229.pub4.\nSimin, 2017, Menopausal hormone therapy and cancer risk: an overestimated risk?, Eur J Cancer Oxf Engl, 84, 60, 10.1016\u002Fj.ejca.2017.07.012\nAnderson, 2004, Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial, JAMA, 291, 1701, 10.1001\u002Fjama.291.14.1701\nCanonico, 2016, Postmenopausal hormone therapy and risk of stroke: impact of the route of estrogen administration and type of progestogen, Stroke, 47, 1734, 10.1161\u002FSTROKEAHA.116.013052\nRovinski, 2018, Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: a systematic review and meta-analysis, Thromb Res, 168, 83, 10.1016\u002Fj.thromres.2018.06.014\nVinogradova, 2020, Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases, BMJ, 371, m3873, 10.1136\u002Fbmj.m3873\nCanonico, 2007, Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study, Circulation, 115, 840, 10.1161\u002FCIRCULATIONAHA.106.642280\nCanonico, 2010, Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study, Arterioscler Thromb Vasc Biol, 30, 340, 10.1161\u002FATVBAHA.109.196022\nScarabin, 2018, Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis, Climacteric, 21, 341, 10.1080\u002F13697137.2018.1446931\nCurb, 2006, Venous thrombosis and conjugated equine estrogen in women without a uterus, Arch Intern Med, 166, 772, 10.1001\u002Farchinte.166.7.772\nCushman, 2004, Estrogen plus progestin and risk of venous thrombosis, JAMA, 292, 1573, 10.1001\u002Fjama.292.13.1573\nCanonico, 2006, Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER study, J Thromb Haemost, 4, 1259, 10.1111\u002Fj.1538-7836.2006.01933.x\nSweetland, 2012, Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study, J Thromb Haemost, 10, 2277, 10.1111\u002Fj.1538-7836.2012.04919.x\nVinogradova, 2019, Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases, BMJ, 364, k4810, 10.1136\u002Fbmj.k4810\nPoudou, 2021, Benefit-risk balance of hormone replacement therapy: cancers and mortality. Postmenopausal women management - CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 462\nFournier, 2014, Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort, Breast Cancer Res Treat, 145, 535, 10.1007\u002Fs10549-014-2934-6\nCordina-Duverger, 2013, Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France, PloS One, 8, 10.1371\u002Fjournal.pone.0078016\nBeral, 2011, Breast cancer risk in relation to the interval between menopause and starting hormone therapy, J Natl Cancer Inst, 103, 296, 10.1093\u002Fjnci\u002Fdjq527\nBeral, 2003, Breast cancer and hormone-replacement therapy in the Million Women Study, Lancet, 362, 419, 10.1016\u002FS0140-6736(03)14065-2\nCollins, 2005, Breast cancer risk with postmenopausal hormonal treatment, Hum Reprod Update, 11, 545, 10.1093\u002Fhumupd\u002Fdmi028\nGrady, 1995, Hormone replacement therapy and endometrial cancer risk: a meta-analysis, Obstet Gynecol, 85, 304, 10.1016\u002F0029-7844(94)00383-O\nAllen, 2010, Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition, Am J Epidemiol, 172, 1394, 10.1093\u002Faje\u002Fkwq300\nBrinton, 2014, Menopausal hormone therapy and risk of endometrial cancer, J Steroid Biochem Mol Biol, 142, 83, 10.1016\u002Fj.jsbmb.2013.05.001\nBeresford, 1997, Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women, Lancet, 349, 458, 10.1016\u002FS0140-6736(96)07365-5\nJaakkola, 2009, Endometrial cancer in postmenopausal women using estradiol-progestin therapy, Obstet Gynecol, 114, 1197, 10.1097\u002FAOG.0b013e3181bea950\nFournier, 2014, Risks of endometrial cancer associated with different hormone replacement therapies in the E3N cohort, 1992-2008, Am J Epidemiol, 180, 508, 10.1093\u002Faje\u002Fkwu146\nLiu, 2019, Menopausal hormone replacement therapy and the risk of ovarian cancer: a meta-analysis, Front Endocrinol (Lausanne), 10, 801, 10.3389\u002Ffendo.2019.00801\nAvis, 2015, Duration of menopausal vasomotor symptoms over the menopause transition, JAMA Intern Med, 175, 531, 10.1001\u002Fjamainternmed.2014.8063\nRaccah-Tebeka, 2021, Non-hormonal alternatives for the management of menopausal hot flushes. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 373\nRance, 2013, Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot flushes, Front Neuroendocrinol, 34, 211, 10.1016\u002Fj.yfrne.2013.07.003\nPrague, 2017, Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial, Lancet, 389, 1809, 10.1016\u002FS0140-6736(17)30823-1\nGosset, 2021, Menopause hormone treatment in practice. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 358\nDepypere, 2015, The levonorgestrel-releasing intrauterine system for endometrial protection during estrogen replacement therapy: a clinical review, Climacteric, 18, 470, 10.3109\u002F13697137.2014.991302\nRaudaskoski, 2002, Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response, BJOG, 109, 136\nTrémollieres, 2021, Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines (short version), Gynecol Obstet Fertil Senol, 49, 305\nHaimov-Kochman, 2006, Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: a randomized prospective study, Menopause, 13, 370\nAslan, 2007, How best is to discontinue postmenopausal hormone therapy: immediate or tapered?, Maturitas, 56, 78, 10.1016\u002Fj.maturitas.2006.06.006\nLindh-Astrand, 2010, A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms, Menopause, 17, 72, 10.1097\u002Fgme.0b013e3181b397c7\nPerrone, 2013, Menopausal symptoms after the discontinuation of long-term hormone replacement therapy in women under 60: a 3-year follow-up, Gynecol Obstet Invest, 76, 38, 10.1159\u002F000351104\nMaclennan, 2004, Oral oestrogen and combined oestrogen\u002Fprogestogen therapy versus placebo for hot flushes, Cochrane Database Syst Rev, 4\nDesmarais, 2010, Managing menopausal symptoms and depression in tamoxifen users: implications of drug and medicinal interactions, Maturitas, 67, 296, 10.1016\u002Fj.maturitas.2010.08.005\nHenry, 2008, Drug interactions and pharmacogenomics in the treatment of breast cancer and depression, Am J Psychiatry, 165, 1251, 10.1176\u002Fappi.ajp.2008.08040482\nLethaby, 2013, Phytoestrogens for menopausal vasomotor symptoms, Cochrane Database Syst Rev, 12, CD001395\nSrisukho, 2019, The experience of genitourinary syndrome of menopause (GSM) among Thai postmenopausal women: the non-reporting issue, Int Urogynecol J, 30, 1843, 10.1007\u002Fs00192-019-03991-0\nSzymański, 2018, Genitourinary syndrome of menopause – is the problem solved? State of the art 2018, Prz Menopauzalny, 17, 168\nCastelo-Branco, 2005, Management of post-menopausal vaginal atrophy and atrophic vaginitis, Maturitas, 52, S46, 10.1016\u002Fj.maturitas.2005.06.014\nPinkerton, 2017, Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning, Maturitas, 100, 57, 10.1016\u002Fj.maturitas.2017.03.315\nBachmann, 2000, Diagnosis and treatment of atrophic vaginitis, Am Fam Physician, 61, 3090\nKarakoç, 2019, Genitourinary syndrome of menopause: effects on related factors, quality of life, and self-care power, Prz Menopauzalny, 18, 15\nPastore, 2004, Self-reported urogenital symptoms in postmenopausal women: Women's Health Initiative, Maturitas, 49, 292, 10.1016\u002Fj.maturitas.2004.06.019\nMac Bride, 2010, Vulvovaginal atrophy, Mayo Clin Proc, 85, 87, 10.4065\u002Fmcp.2009.0413\nCardozo, 1998, Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee, Obstet Gynecol, 92, 722\nBarnabei, 2005, Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative, Obstet Gynecol, 105, 1063, 10.1097\u002F01.AOG.0000158120.47542.18\nFantl, 1996, Efficacy of estrogen supplementation in the treatment of urinary incontinence. The Continence Program for Women Research Group, Obstet Gynecol, 88, 745, 10.1016\u002F0029-7844(96)00281-5\nRufford, 2003, A double-blind placebo-controlled trial on the effects of 25 mg estradiol implants on the urge syndrome in postmenopausal women, Int Urogynecol J Pelvic Floor Dysfunct, 14, 78, 10.1007\u002Fs00192-003-1054-3\nSteinauer, 2005, Postmenopausal hormone therapy: does it cause incontinence?, Obstet Gynecol, 106, 940, 10.1097\u002F01.AOG.0000180394.08406.15\nHendrix, 2005, Effects of estrogen with and without progestin on urinary incontinence, JAMA, 293, 935, 10.1001\u002Fjama.293.8.935\nWaetjen, 2005, The effect of ultralow-dose transdermal estradiol on urinary incontinence in postmenopausal women, Obstet Gynecol, 106, 946, 10.1097\u002F01.AOG.0000182576.48290.6d\nSulaica, 2016, Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy, Breast Cancer Res Treat, 157, 203, 10.1007\u002Fs10549-016-3827-7\nMaris, 2021, Management of vulvovaginal atrophy: Physical therapies. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 414\nGambacciani, 2015, Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause, Climacteric, 18, 757, 10.3109\u002F13697137.2015.1045485\nGaspar, 2017, Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause, Lasers Surg Med, 49, 160, 10.1002\u002Flsm.22569\nCruz, 2018, Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women, Menopause, 25, 21, 10.1097\u002FGME.0000000000000955\nRuanphoo, 2020, Treatment for vaginal atrophy using microablative fractional CO2 laser: a randomized double-blinded sham-controlled trial, Menopause, 27, 858, 10.1097\u002FGME.0000000000001542\nJha, 2019, The impact of vaginal laser treatment for genitourinary syndrome of menopause in breast cancer survivors: a systematic review and meta-analysis, Clin Breast Cancer, 19, e556, 10.1016\u002Fj.clbc.2019.04.007\nPreti, 2019, The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: an ICS\u002FISSVD best practice consensus document, J Low Genit Tract Dis, 23, 151, 10.1097\u002FLGT.0000000000000462\nKanis, 2005, Assessment of fracture risk, Osteoporos Int, 16, 581, 10.1007\u002Fs00198-004-1780-5\nSornay-Rendu, 2014, How to predict fragility fracture beyond 10 years? The OFELY study, J Clin Endocrinol Metab, 99, 4690, 10.1210\u002Fjc.2014-2601\nLeslie, 2011, A review of osteoporosis diagnosis and treatment options in new and recently updated guidelines on case finding around the world, Curr Osteoporos Rep, 9, 129, 10.1007\u002Fs11914-011-0060-5\nBriot, 2018, 2018 update of French recommendations on the management of postmenopausal osteoporosis, Joint Bone Spine, 85, 519, 10.1016\u002Fj.jbspin.2018.02.009\nHaute Autorité de santé. Les médicaments de l’ostéoporose 2019.\nRiggs, 2004, Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites, J Bone Miner Res, 19, 1945, 10.1359\u002Fjbmr.040916\nSowers, 2013, Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity, J Clin Endocrinol Metab, 98, 2854, 10.1210\u002Fjc.2012-4113\nGRIO. Actualisation 2017 des recommandations de traitement de l’ostéoporosepost ménopausique 2017. www.grio.org\u002Fdocuments\u002Fpage240\u002Frecommandations-pmo-actualisation-2017.pdf.\nWeiss, 1999, A randomized controlled trial of four doses of transdermal estradiol for preventing postmenopausal bone loss. Transdermal Estradiol Investigator Group, Obstet Gynecol, 94, 330\nDelmas, 1999, A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group, Bone, 24, 517, 10.1016\u002FS8756-3282(99)00076-9\nHeikkinen, 2000, Long-term continuous combined hormone replacement therapy in the prevention of postmenopausal bone loss: a comparison of high- and low-dose estrogen-progestin regimens, Osteoporos Int, 11, 929, 10.1007\u002Fs001980070031\nGartlehner, 2017, Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: evidence report and systematic review for the US Preventive Services Task Force, JAMA, 318, 2234, 10.1001\u002Fjama.2017.16952\nBanks, 2004, Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women, JAMA, 291, 2212, 10.1001\u002Fjama.291.18.2212\nWasnich, 2004, Changes in bone density and turnover after alendronate or estrogen withdrawal, Menopause, 11, 622, 10.1097\u002F01.GME.0000123641.76105.B5\nGallagher, 2002, Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers, J Clin Endocrinol Metab, 87, 4914, 10.1210\u002Fjc.2002-020727\nHocké, 2021, Syndrome génito-urinaire de la ménopause (SGUM). RPC les femmes ménopausées du CNGOF et du GEMVi, Gynecol Obstr Fertil Senol, 49, 394",{"ES":940},{"VOID":946},"10.1016\u002Fs1283-081x(23)47976-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X23479763",[949,964,976,988,1000,1012,1024,1036,1048,1060,1077,1089,1101,1113,1125,1137,1149,1161,1173,1185],{"id":950,"sortIndex":135,"researcher":26,"roles":951,"affiliations":952,"properties":961},"ff39c540-6905-45c7-ba30-f671547b2723",[696],[953],{"id":26,"sortIndex":36,"affiliation":954,"properties":26},{"id":955,"createTime":956,"updateTime":956,"relativeEntities":957,"slug":26,"properties":958,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"6c598c7e-c70e-4873-95d3-10c61b40e56a","2023-12-02T12:30:19.889+00:00",[],{"title":959},{"VI":960},"Collège national des gynécologues et obstétriciens français, Groupe d’étude sur la ménopause et le vieillissement hormonal, Groupe de travail « Recommandation pour la pratique Clinique 2021: les femmes ménopausées », Paris, France",{"title":962},{"VI":963},"J.-M. Pouille",{"id":965,"sortIndex":51,"researcher":26,"roles":966,"affiliations":967,"properties":973},"716f2bd8-4a87-4c40-aaba-8ed515a100e8",[696],[968],{"id":26,"sortIndex":36,"affiliation":969,"properties":26},{"id":955,"createTime":956,"updateTime":956,"relativeEntities":970,"slug":26,"properties":971,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":972},{"VI":960},{"title":974},{"VI":975},"N. Hamdaoui",{"id":977,"sortIndex":53,"researcher":26,"roles":978,"affiliations":979,"properties":985},"db0da6bd-a139-4ccc-ab33-5d353c7a1b2e",[696],[980],{"id":26,"sortIndex":36,"affiliation":981,"properties":26},{"id":955,"createTime":956,"updateTime":956,"relativeEntities":982,"slug":26,"properties":983,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":984},{"VI":960},{"title":986},{"VI":987},"J. Hugon-Rodin",{"id":989,"sortIndex":298,"researcher":26,"roles":990,"affiliations":991,"properties":997},"6d30f934-d7f9-4283-9612-ac3aba3cfb0e",[696],[992],{"id":26,"sortIndex":36,"affiliation":993,"properties":26},{"id":955,"createTime":956,"updateTime":956,"relativeEntities":994,"slug":26,"properties":995,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":996},{"VI":960},{"title":998},{"VI":999},"G. André",{"id":1001,"sortIndex":162,"researcher":26,"roles":1002,"affiliations":1003,"properties":1009},"601a1d29-553e-4a98-a5c5-7423aac86e0e",[696],[1004],{"id":26,"sortIndex":36,"affiliation":1005,"properties":26},{"id":955,"createTime":956,"updateTime":956,"relativeEntities":1006,"slug":26,"properties":1007,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1008},{"VI":960},{"title":1010},{"VI":1011},"M. Duclos",{"id":1013,"sortIndex":173,"researcher":26,"roles":1014,"affiliations":1015,"properties":1021},"adb5c12d-9967-4da2-ae28-90f05034e0fe",[696],[1016],{"id":26,"sortIndex":36,"affiliation":1017,"properties":26},{"id":955,"createTime":956,"updateTime":956,"relativeEntities":1018,"slug":26,"properties":1019,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1020},{"VI":960},{"title":1022},{"VI":1023},"X. Fritel",{"id":1025,"sortIndex":234,"researcher":26,"roles":1026,"affiliations":1027,"properties":1033},"48101ac1-40be-472b-979e-d0c0e14b44b2",[696],[1028],{"id":26,"sortIndex":36,"affiliation":1029,"properties":26},{"id":955,"createTime":956,"updateTime":956,"relativeEntities":1030,"slug":26,"properties":1031,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1032},{"VI":960},{"title":1034},{"VI":1035},"O. Graesslin",{"id":1037,"sortIndex":336,"researcher":26,"roles":1038,"affiliations":1039,"properties":1045},"263ebcd7-675f-479a-b53d-d03642cb5a95",[696],[1040],{"id":26,"sortIndex":36,"affiliation":1041,"properties":26},{"id":955,"createTime":956,"updateTime":956,"relativeEntities":1042,"slug":26,"properties":1043,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1044},{"VI":960},{"title":1046},{"VI":1047},"C. Mathelin",{"id":1049,"sortIndex":158,"researcher":26,"roles":1050,"affiliations":1051,"properties":1057},"527bbe33-b750-4d3c-b958-7a4a44069cd1",[696],[1052],{"id":26,"sortIndex":36,"affiliation":1053,"properties":26},{"id":955,"createTime":956,"updateTime":956,"relativeEntities":1054,"slug":26,"properties":1055,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1056},{"VI":960},{"title":1058},{"VI":1059},"A. Gosset",{"id":1061,"sortIndex":36,"researcher":26,"roles":1062,"affiliations":1063,"properties":1074},"1778a412-5429-47f6-b380-130f2196a836",[696],[1064],{"id":26,"sortIndex":36,"affiliation":1065,"properties":26},{"id":1066,"createTime":1067,"updateTime":1068,"relativeEntities":1069,"slug":1070,"properties":1071,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"0523ed73-f6f8-4b89-9ae5-2f5e91940931","2023-12-02T12:30:19.804+00:00","2025-06-11T18:20:31.093+00:00",[],"Service-de-gyn%C3%A9cologie-obst%C3%A9trique-m%C3%A9decine-de-la-reproduction-H%C3%B4pital-Tenon-AP-HP-Sorbonne-Universit%C3%A9-4-rue-de-la-Chine-75020-Paris-France",{"title":1072},{"VI":1073},"Service de gynécologie obstétrique médecine de la reproduction, Hôpital Tenon, AP–HP, Sorbonne Université, 4 rue de la Chine, 75020 Paris, France",{"title":1075},{"VI":1076},"N. Chabbert-Buffet",{"id":1078,"sortIndex":59,"researcher":26,"roles":1079,"affiliations":1080,"properties":1086},"a16e47f4-64e1-414f-96f9-f8b4be1318e1",[696],[1081],{"id":26,"sortIndex":36,"affiliation":1082,"properties":26},{"id":955,"createTime":956,"updateTime":956,"relativeEntities":1083,"slug":26,"properties":1084,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1085},{"VI":960},{"title":1087},{"VI":1088},"C. Rousset-Jablonski",{"id":1090,"sortIndex":124,"researcher":26,"roles":1091,"affiliations":1092,"properties":1098},"2df716cb-0ba4-4e19-afa4-b9f7208f1bad",[696],[1093],{"id":26,"sortIndex":36,"affiliation":1094,"properties":26},{"id":955,"createTime":956,"updateTime":956,"relativeEntities":1095,"slug":26,"properties":1096,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1097},{"VI":960},{"title":1099},{"VI":1100},"P. Lopes",{"id":1102,"sortIndex":116,"researcher":26,"roles":1103,"affiliations":1104,"properties":1110},"d04c02cd-1fab-4835-b3b9-dc4fccecd5d5",[696],[1105],{"id":26,"sortIndex":36,"affiliation":1106,"properties":26},{"id":955,"createTime":956,"updateTime":956,"relativeEntities":1107,"slug":26,"properties":1108,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1109},{"VI":960},{"title":1111},{"VI":1112},"E. Maris",{"id":1114,"sortIndex":114,"researcher":26,"roles":1115,"affiliations":1116,"properties":1122},"4db97be7-9be9-4075-b6e0-4c5b6a374750",[696],[1117],{"id":26,"sortIndex":36,"affiliation":1118,"properties":26},{"id":955,"createTime":956,"updateTime":956,"relativeEntities":1119,"slug":26,"properties":1120,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1121},{"VI":960},{"title":1123},{"VI":1124},"G. Plu-Bureau",{"id":1126,"sortIndex":111,"researcher":26,"roles":1127,"affiliations":1128,"properties":1134},"8329402b-35cf-4eb6-b7dd-aa8527e8ee2a",[696],[1129],{"id":26,"sortIndex":36,"affiliation":1130,"properties":26},{"id":955,"createTime":956,"updateTime":956,"relativeEntities":1131,"slug":26,"properties":1132,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1133},{"VI":960},{"title":1135},{"VI":1136},"J.-M. Lecerf",{"id":1138,"sortIndex":115,"researcher":26,"roles":1139,"affiliations":1140,"properties":1146},"7267bb95-824a-475c-bf1c-9773b9a59886",[696],[1141],{"id":26,"sortIndex":36,"affiliation":1142,"properties":26},{"id":955,"createTime":956,"updateTime":956,"relativeEntities":1143,"slug":26,"properties":1144,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1145},{"VI":960},{"title":1147},{"VI":1148},"F. Trémollieres",{"id":1150,"sortIndex":356,"researcher":26,"roles":1151,"affiliations":1152,"properties":1158},"20d4868c-d9e8-4eae-bd04-032e8f16942e",[696],[1153],{"id":26,"sortIndex":36,"affiliation":1154,"properties":26},{"id":955,"createTime":956,"updateTime":956,"relativeEntities":1155,"slug":26,"properties":1156,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1157},{"VI":960},{"title":1159},{"VI":1160},"G. Robin",{"id":1162,"sortIndex":103,"researcher":26,"roles":1163,"affiliations":1164,"properties":1170},"831a096c-14b8-429b-97de-3fcf4b95f1b5",[696],[1165],{"id":26,"sortIndex":36,"affiliation":1166,"properties":26},{"id":955,"createTime":956,"updateTime":956,"relativeEntities":1167,"slug":26,"properties":1168,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1169},{"VI":960},{"title":1171},{"VI":1172},"L. Maitrot-Mantelet",{"id":1174,"sortIndex":50,"researcher":26,"roles":1175,"affiliations":1176,"properties":1182},"44247774-6183-48ef-9860-738229f683b6",[696],[1177],{"id":26,"sortIndex":36,"affiliation":1178,"properties":26},{"id":955,"createTime":956,"updateTime":956,"relativeEntities":1179,"slug":26,"properties":1180,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1181},{"VI":960},{"title":1183},{"VI":1184},"G. Boutet",{"id":1186,"sortIndex":52,"researcher":26,"roles":1187,"affiliations":1188,"properties":1194},"c151b938-5903-41bb-ac5c-c59a7172515b",[696],[1189],{"id":26,"sortIndex":36,"affiliation":1190,"properties":26},{"id":955,"createTime":956,"updateTime":956,"relativeEntities":1191,"slug":26,"properties":1192,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1193},{"VI":960},{"title":1195},{"VI":1196},"C. Hocké",{"url":947,"publisher":1198,"properties":1206},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1199,"slug":662,"properties":1200,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1203,"manageAffiliations":1204,"indexDatabases":1205,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1201,"title":1202},{"VOID":665},{"EN":667},[],[],[],{"volume":1207,"pages":1209},{"VOID":1208},"59",{"VOID":866},"2023-09-01",2023,{"id":1213,"createTime":1214,"updateTime":1214,"relativeEntities":1215,"slug":1216,"properties":1217,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1224,"fullTextUrl":26,"authors":1225,"publicationType":747,"publisherRelationship":1271,"citationCount":26,"citationInfo":26,"publishDate":1284,"publishYear":1285,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"a1761522-6120-48d3-bcb7-4a62c847c458","2023-11-30T06:21:53.407+00:00",[],"F%C3%A1rmacos-tocol%C3%ADticos",{"references":1218,"title":1220,"doi":1222},{"VOID":1219},"Sentilhes, 2016, Recommandations pour la pratique clinique : prévention de la prématurité spontanée et de ses conséquences (hors rupture des membranes) –Texte des recommandations, J Gynecol Obstet Biol Reprod, 45, 1446, 10.1016\u002Fj.jgyn.2016.09.011\nDoret, 2016, La tocolyse en cas de menace d’accouchement prématuré à membranes intactes, J Gynecol Obstet Biol Reprod, 45, 1374, 10.1016\u002Fj.jgyn.2016.09.018\nNeilson, 2014, Betamimetics for inhibiting preterm labour, Cochrane Database Syst Rev, CD004352\nHaas, 2012, Tocolytic therapy for preterm delivery: systematic review and network meta-analysis, BMJ, 345, e6226, 10.1136\u002Fbmj.e6226\nFlenady, 2014, Oxytocin receptor antagonists for inhibiting preterm labour, Cochrane Database Syst Rev, CD004452\nHaas, 2009, Tocolytic therapy: a meta-analysis and decision analysis, Obstet Gynecol, 113, 585, 10.1097\u002FAOG.0b013e318199924a\nConde-Agudelo, 2011, Nifedipine in the management of preterm labor: a systematic review and meta-analysis, Am J Obstet Gynecol, 204, 10.1016\u002Fj.ajog.2010.11.038\nTsatsaris, 2001, Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis, Obstet Gynecol, 97, 840\nCoomarasamy, 2002, Oxytocin antagonists for tocolysis in preterm labour -- a systematic review, Med Sci Monit, 8, RA268\nLeveno, 1986, Single-centre randomised trial of ritodrine hydrochloride for preterm labour, Lancet, 1, 1293, 10.1016\u002FS0140-6736(86)91219-5\nde Heus, 2009, Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study, BMJ, 338, b744, 10.1136\u002Fbmj.b744\nMabie, 1983, Pulmonary edema induced by betamimetic drugs, South Med J, 76, 1354, 10.1097\u002F00007611-198311000-00007\nDudenhausen, 2006, “Normal” pregnancy with adverse events on initial tocolytic treatment, BJOG, 113, 116, 10.1111\u002Fj.1471-0528.2006.01138.x\nPaternoster, 2004, Maternal complications from tocolytic treatment with ritodrine. Three cases of pulmonary edema, Minerva Ginecol, 56, 491\nKaraman, 2004, Pulmonary edema after ritodrine therapy during pregnancy and subsequent cesarean section with epidural anesthesia, Clin Exp Obstet Gynecol, 31, 67\nHamel, 2002, [Pulmonary edema and tocolysis with beta-agonists], Rev Mal Respir, 19, 241\nMilos, 1988, Maternal pulmonary edema complicating beta-adrenergic therapy of preterm labor, AJR Am J Roentgenol, 151, 917, 10.2214\u002Fajr.151.5.917\nEvron, 1983, [Pulmonary edema occurring after isoxsuprine treatment for preterm labor], Harefuah, 105, 287\nBenedetti, 1982, Maternal pulmonary edema during premature labor inhibition, Obstet Gynecol, 59\nStubblefield, 1978, Pulmonary edema occurring after therapy with dexamethasone and terbutaline for premature labor: a case report, Am J Obstet Gynecol, 132, 341, 10.1016\u002F0002-9378(78)90907-9\nNagey, 1982, Pulmonary complications of isoxsuprine therapy in the gravida, Obstet Gynecol, 59\nJacobs, 1980, Maternal pulmonary edema resulting from betamimetic and glucocorticoid therapy, Obstet Gynecol, 56, 56\nGuernsey, 1981, Pulmonary edema associated with the use of betamimetic agents in preterm labor, Am J Hosp Pharm, 38, 1942\nBrosset, 1982, Cardiac complications of ritodrine in mother and baby, Lancet, 1, 1468, 10.1016\u002FS0140-6736(82)92476-X\nCarson, 2002, Atrial fibrillation in pregnancy associated with oral terbutaline, Obstet Gynecol, 100, 1096\nAbramovici, 1980, Maternal pulmonary edema occurring after therapy with ritodrine for premature uterine contractions, Acta Obstet Gynecol Scand, 59, 555, 10.3109\u002F00016348009155450\nDordević, 2002, [Successful resuscitation of a patient with prolonged tocolytic therapy and an emergency cesarean section], Vojnosanit Pregl, 59, 325, 10.2298\u002FVSP0203325D\nMagnus, 1987, [Myocardial infarction during tocolysis with sympathomimetics], Tidsskr Nor Laegeforen, 107, 943\nKotoujansky, 1985, [Tocolysis using salbutamol in cases of cardiac rhythm disorders in the mother. Apropos of 4 cases], J Gynecol Obstet Biol Reprod, 14, 915\nZhang, 2014, Ritodrine-induced agranulocytosis in pregnancy, J Obstet Gynaecol, 34, 533, 10.3109\u002F01443615.2014.914481\nYasuda, 2012, Agranulocytosis associated with intravenous ritodrine hydrochloride therapy: two case reports by different mechanisms, J Obstet Gynaecol Res, 38, 574, 10.1111\u002Fj.1447-0756.2011.01756.x\nKikkawa, 2008, Granulocyte-colony stimulating factor for the treatment of ritodrine-induced neutropenia, J Obstet Gynaecol Res, 34, 286, 10.1111\u002Fj.1447-0756.2008.00773.x\nMuro, 1991, Ritodrine-induced agranulocytosis, Int J Gynaecol Obstet, 36, 329, 10.1016\u002F0020-7292(91)90488-Q\nVerriello, 2009, Rhabdomyolysis caused by tocolytic therapy with ritodrine hydrochloride, Neuromuscul Disord, 19, 718, 10.1016\u002Fj.nmd.2009.06.364\nNasu, 2006, Rhabdomyolysis caused by tocolysis with oral ritodrine hydrochloride in a pregnant patient with myotonic dystrophy, Gynecol Obstet Invest, 1, 53, 10.1159\u002F000088531\nRosene, 1982, Cerebral ischemia associated with parenteral terbutaline use in pregnant migraine patients, Am J Obstet Gynecol, 143, 405, 10.1016\u002F0002-9378(82)90081-3\nHudgens, 1993, Sudden death associated with terbutaline sulfate administration, Am J Obstet Gynecol, 169, 120, 10.1016\u002F0002-9378(93)90144-8\nMilliez, 1980, A case report of maternal death associated with betamimetics and betamethasone administration in premature labor, Eur J Obstet Gynecol Reprod Biol, 11, 95, 10.1016\u002F0028-2243(80)90014-3\nRäsänen, 1990, The effects of ritodrine infusion on fetal myocardial function and fetal hemodynamics, Acta Obstet Gynecol Scand, 69, 487, 10.3109\u002F00016349009013323\nGokay, 2001, Changes in fetal hemodynamics with ritodrine tocolysis, Ultrasound Obstet Gynecol, 18, 44, 10.1046\u002Fj.1469-0705.2001.00453.x\nBrar, 1988, Maternal and fetal blood flow velocity waveforms in patients with preterm labor: effect of tocolytics, Obstet Gynecol, 72, 209\nWitter, 2009, In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes, Am J Obstet Gynecol, 201, 553, 10.1016\u002Fj.ajog.2009.07.010\nConnors, 2005, Beta2-adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins, J Child Neurol, 20, 876, 10.1177\u002F08830738050200110401\nPitzer, 2001, Child development after maternal tocolysis with beta-sympathomimetic drugs, Child Psychiatry Hum Dev, 31, 165, 10.1023\u002FA:1026419720410\nHadders-Algra, 1986, Long-term follow-up of children prenatally exposed to ritodrine, Br J Obstet Gynaecol, 93, 156, 10.1111\u002Fj.1471-0528.1986.tb07880.x\nFreysz, 1977, A long term evaluation of infants who received a beta-mimetic drug while in utero, J Perinat Med, 5, 94, 10.1515\u002Fjpme.1977.5.2.94\nGidaya, 2016, In utero exposure to β-2-adrenergic receptor agonist drugs and risk for autism spectrum disorders, Pediatrics, 137, e20151316, 10.1542\u002Fpeds.2015-1316\nNICE. Preterm Labour and Birth [Internet]. London: National Institute for Health and Care Excellence (UK); 2015.\nRomero, 2000, An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue, Am J Obstet Gynecol, 182, 1173, 10.1067\u002Fmob.2000.95834\nvan Vliet, 2016, Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial, Lancet, 387, 2117, 10.1016\u002FS0140-6736(16)00548-1\nAl-Omari, 2006, Atosiban and nifedipine in acute tocolysis: a comparative study, Eur J Obstet Gynecol Reprod Biol, 128, 129, 10.1016\u002Fj.ejogrb.2005.12.010\nSalim, 2012, Nifedipine compared with atosiban for treating preterm labor: a randomized controlled trial, Obstet Gynecol, 120, 1323, 10.1097\u002FAOG.0b013e3182755dff\nSeinen, 2013, [Maternal pulmonary oedema due to the use of atosiban in cases of multiple gestation], Ned Tijdschr Geneeskd, 157, A5316\nFernández, 2011, Severe non-cardiogenic pulmonary oedema secondary to atosiban and steroids, Int J Obstet Anesth, 20, 189, 10.1016\u002Fj.ijoa.2010.09.003\nFerguson, 1990, A comparison of tocolysis with nifedipine or ritodrine: analysis of efficacy and maternal, fetal, and neonatal outcome, Am J Obstet Gynecol, 163, 105, 10.1016\u002FS0002-9378(11)90679-6\nSilberschmidt, 2008, Nifedipine concentration in maternal and umbilical cord blood after nifedipine gastrointestinal therapeutic system for tocolysis, BJOG, 115, 480, 10.1111\u002Fj.1471-0528.2007.01630.x\nClouqueur, 2015, [Adverse effects of calcium channels blockers used as tocolytic treatment], J Gynecol Obstet Biol Reprod, 44, 341, 10.1016\u002Fj.jgyn.2014.12.012\nFlenady, 2014, Calcium channel blockers for inhibiting preterm labour and birth, Cochrane Database Syst Rev, CD002255\nAra, 2008, A prospective randomised trial of nifedipine versus placebo in preterm labour, Bangladesh J Obstet Gynaecol, 23, 61, 10.3329\u002Fbjog.v23i2.4962\nZhang, 2002, [Clinical observations on the prevention and treatment of premature labor with nifedipine], Hua Xi Yi Ke Da Xue Xue Bao, 33, 288\nBejan-Angoulvant, 2015, [Calcium channel blockers pharmacology and their use as tocolytics], J Gynecol Obstet Biol Reprod, 44, 305, 10.1016\u002Fj.jgyn.2014.12.010\nParant, 2015, [Use of calcium channel blockers (CCB) for tocolysis in France and abroad], J Gynecol Obstet Biol Reprod, 44, 312, 10.1016\u002Fj.jgyn.2014.12.016\nLe Ray, 2010, [Nifedipine or nicardipine in management of threatened preterm delivery: an observational population-based study], J Gynecol Obstet Biol Reprod, 39, 490, 10.1016\u002Fj.jgyn.2010.04.004\nLaas, 2012, [Comparison of the rate of maternal complications of nifedipine and nicardipine in cases of preterm labor: historical study on two consecutive periods], J Gynecol Obstet Biol Reprod, 41, 631, 10.1016\u002Fj.jgyn.2012.04.020\nMcGuirl J, Arzuaga B, Lee BH. Antenatal calcium channel blocker exposure and subsequent patent ductus arteriosus in extremely low-birth-weight infants. Pediatr Cardiol 2012;33:60–4.\nSmith, 2007, Randomized double-blind placebo-controlled trial of transdermal nitroglycerin for preterm labor, Am J Obstet Gynecol, 196, 10.1016\u002Fj.ajog.2006.10.868\nHaghighi, 2005, Isosorbide dinitrate for treatment of preterm labor, Int J Gynaecol Obstet, 89, 274, 10.1016\u002Fj.ijgo.2005.03.004\nDuckitt, 2014, Nitric oxide donors for treating preterm labour, Cochrane Database Syst Rev, CD002860\nAmorim, 2009, [Transdermal nitroglycerin versus oral nifedipine administration for tocolysis: a randomized clinical trial], Rev Bras Ginecol Obstet, 31, 552\nCrowther, 2014, Magnesium sulphate for preventing preterm birth in threatened preterm labour, Cochrane Database Syst Rev, CD001060\nReinebrant, 2015, Cyclo-oxygenase (COX) inhibitors for treating preterm labour, Cochrane Database Syst Rev, CD001992\nErny, 1986, The effects of oral administration of progesterone for premature labor, Am J Obstet Gynecol, 154, 525, 10.1016\u002F0002-9378(86)90595-8\nChawanpaiboon, 2011, Comparison of success rate of nifedipine, progesterone, and bed rest for inhibiting uterine contraction in threatened preterm labor, J Obstet Gynaecol Res, 37, 787, 10.1111\u002Fj.1447-0756.2010.01434.x\nSu, 2014, Progestational agents for treating threatened or established preterm labour, Cochrane Database Syst Rev, CD006770\nKCE. Prévention de l’accouchement prématuré chez les femmes à risque – Évaluation de quelques mesures courantes. https:\u002F\u002Fkce.fgov.be\u002Ffr\u002Fpr%C3%A9vention-de-l%E2%80%99accouchement-pr%C3%A9matur%C3%A9-chez-les-femmes-%C3%A0-risque-%E2%80%93-evaluation-de-quelques-mesures.\n[No authors listed]. Practice Bulletin No. 159: Management of Preterm Labor. Obstet Gynecol 2016;127:e29–38.\nOrganisation mondiale de la santé. Recommandations de l’OMS sur les interventions visant à améliorer l’issue des naissances prématurées. Août 2015. http:\u002F\u002Fapps.who.int\u002Firis\u002Fbitstream\u002F10665\u002F200219\u002F1\u002FWHO_RHR_15.16_fre.pdf?ua=1.\nVeille, 1985, Maternal cardiovascular adaptations to twin pregnancy, Am J Obstet Gynecol, 153, 261, 10.1016\u002FS0002-9378(85)80109-5\nDodd, 2012, Oral betamimetics for maintenance therapy after threatened preterm labour, Cochrane Database Syst Rev, 12, CD003927\nChawanpaiboon, 2014, Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes, Cochrane Database Syst Rev, CD010800\nHan, 2013, Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour, Cochrane Database Syst Rev, CD000940\nNaik Gaunekar, 2013, Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour, Cochrane Database Syst Rev, CD004071\nRoos, 2013, Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial, JAMA, 309, 41, 10.1001\u002Fjama.2012.153817\nParry, 2014, The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour, Aust N Z J Obstet Gynaecol, 54, 231, 10.1111\u002Fajo.12179\nPapatsonis, 2013, Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour, Cochrane Database Syst Rev, CD005938\nVogel, 2014, Combination of tocolytic agents for inhibiting preterm labour, Cochrane Database Syst Rev, CD006169\nManuck, 2015, Tocolysis for women with early spontaneous preterm labor and advanced cervical dilation, Obstet Gynecol, 126, 954, 10.1097\u002FAOG.0000000000001095\nde Veciana, 1995, Tocolysis in advanced preterm labor: impact on neonatal outcome, Am J Perinatol, 12, 294, 10.1055\u002Fs-2007-994478\nAmon, 2000, Tocolysis with advanced cervical dilatation, Obstet Gynecol, 95, 358\nKlauser, 2016, Tocolysis in women with advanced preterm labor: a secondary analysis of a randomized clinical trial, J Matern Fetal Neonatal Med, 29, 696, 10.3109\u002F14767058.2015.1018171",{"ES":1221},"Fármacos tocolíticos",{"VOID":1223},"10.1016\u002Fs1283-081x(19)42003-1","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X19420031",[1226,1241,1256],{"id":1227,"sortIndex":36,"researcher":26,"roles":1228,"affiliations":1229,"properties":1238},"b43820b1-e054-4ee3-ac76-3d9ee61394fc",[696],[1230],{"id":26,"sortIndex":36,"affiliation":1231,"properties":26},{"id":1232,"createTime":1233,"updateTime":1233,"relativeEntities":1234,"slug":26,"properties":1235,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"28f2c27d-a0a5-47ac-889a-e2fbc3dcd77a","2023-11-30T06:21:53.446+00:00",[],{"title":1236},{"VI":1237},"Service de gynécologie obstétrique, Hôpital Femme-Mère-Enfant, Hospices civils de Lyon, 59, boulevard Pinel, 69677 Bron cedex, France",{"title":1239},{"VI":1240},"M. Doret",{"id":1242,"sortIndex":115,"researcher":26,"roles":1243,"affiliations":1244,"properties":1253},"5319dc5e-c1f6-44cb-b32a-142b758b5503",[696],[1245],{"id":26,"sortIndex":36,"affiliation":1246,"properties":26},{"id":1247,"createTime":1248,"updateTime":1248,"relativeEntities":1249,"slug":26,"properties":1250,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"20b165d4-879a-440b-aff8-f3bb9f981f1d","2023-11-30T06:21:53.467+00:00",[],{"title":1251},{"VI":1252},"Service de gynécologie-obstétrique, Hôpital Trousseau, AP–HP, Paris, France",{"title":1254},{"VI":1255},"G. Kayem",{"id":1257,"sortIndex":114,"researcher":26,"roles":1258,"affiliations":1259,"properties":1268},"112b2d8a-62db-4ba9-8b3a-0c80b10d7b98",[696],[1260],{"id":26,"sortIndex":36,"affiliation":1261,"properties":26},{"id":1262,"createTime":1263,"updateTime":1263,"relativeEntities":1264,"slug":26,"properties":1265,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"4c570d3a-0ed7-4288-ab4e-2ec370f4f17a","2023-11-30T06:21:53.515+00:00",[],{"title":1266},{"VI":1267},"Service de gynécologie-obstétrique, Hôpital Pellegrin, CHU de Bordeaux, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France",{"title":1269},{"VI":1270},"L. Sentilhes",{"url":1224,"publisher":1272,"properties":1280},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1273,"slug":662,"properties":1274,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1277,"manageAffiliations":1278,"indexDatabases":1279,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1275,"title":1276},{"VOID":665},{"EN":667},[],[],[],{"volume":1281,"pages":1283},{"VOID":1282},"55",{"VOID":933},"2019-06-01",2019,{"id":1287,"createTime":1288,"updateTime":1289,"relativeEntities":1290,"slug":1291,"properties":1292,"entityType":688,"verifyStatus":25,"verifyTime":1289,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1299,"fullTextUrl":26,"authors":1300,"publicationType":747,"publisherRelationship":1376,"citationCount":26,"citationInfo":26,"publishDate":1390,"publishYear":1391,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"06058d57-08af-47b2-998c-be20b2be0e34","2023-12-13T13:35:41.698+00:00","2025-01-11T17:50:30.306+00:00",[],"Utilidad-de-la-histeroscopia-diagn%C3%B3stica-en-el-estudio-de-la-infertilidad",{"references":1293,"title":1295,"doi":1297},{"VOID":1294},"Merviel, 2000, Place de l'hystéroscopie dans le diagnostic et le traitement de l'infertilité, Presse Méd., 29, 1302\nPrevedourakis, 1994, Hysterosalpingography and hysteroscopy in female infertility, Hum. Reprod., 9, 2353, 10.1093\u002Foxfordjournals.humrep.a138451\nPreutthipan, 2003, A prospective study between hysterosalpingography and hysteroscopy in the detection of intrauterine pathology in patients with infertility, J. Obstet. Gynaecol. Res., 29, 33, 10.1046\u002Fj.1341-8076.2003.00068.x\nWang, 1996, Comparison of hysterosalpingography and hysteroscopy in infertility, J. Am. Assoc. Gynecol. Laparosc., 3, 581, 10.1016\u002FS1074-3804(05)80170-7\nGolan, 1996, Hysteroscopy is superior to hysterosalpingography in infertility investigation, Acta Obstet. Gynecol. Scand., 75, 654, 10.3109\u002F00016349609054692\nLoverro, 2001, Uterine cavity assessment in infertile women: comparison of transvaginal sonography and hysteroscopy, Eur. J. Obstet. Gynecol. Reprod. Biol., 100, 67, 10.1016\u002FS0301-2115(01)00434-1\nShalev, 2000, Predictive value of transvaginal sonography performed before routine diagnostic hysteroscopy for evaluation of infertility, Fertil. Steril., 73, 412, 10.1016\u002FS0015-0282(99)00533-6\nNarayan, 1993, Transvaginal sonography of the uterine cavity with hysteroscopic correlation in the investigation of infertility, Ultrasound Obstet. Gynecol., 3, 129, 10.1046\u002Fj.1469-0705.1993.03020129.x\nSoares, 2000, Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases, Fertil. Steril., 73, 406, 10.1016\u002FS0015-0282(99)00532-4\nHamilton, 1998, Routine use of saline hysterosonography in 500 consecutive, unselected, infertile women, Hum. Reprod., 13, 2463, 10.1093\u002Fhumrep\u002F13.9.2463\nDe Kroon, 2003, Technology assessment of saline contrast hysterosonography, Am. J. Obstet. Gynecol., 188, 945, 10.1067\u002Fmob.2003.264\nBrown, 2000, Evaluation of outpatient hysteroscopy,sline infusion hysterosonography,and hysterosalpingography in infertile women: a prospective, randomized study, Fertil. Steril., 74, 1029, 10.1016\u002FS0015-0282(00)01541-7\nAyida, 1997, Uterine cavity assessment prior to in vitro fertilization: comparison of transvaginal scanning, saline contrast hysterosonography and hysteroscopy, Ultrasound Obstet. Gynecol., 10, 59, 10.1046\u002Fj.1469-0705.1997.10010059.x\nLeone, 2003, Use of strict sonohysterographic methods for preoperative assessment of submucous myomas, Fertil. Steril., 79, 998, 10.1016\u002FS0015-0282(02)04916-6\nGronlund, 1999, Transvaginal sonohysterography and hysteroscopy in the evaluation of female infertility, habitual abortion or metrorrhagia. A comparative study, Acta Obstet. Gynecol. Scand., 78, 415, 10.1080\u002Fj.1600-0412.1999.780513.x\nAlatas, 1997, Evaluation of intrauterine abnormalities in infertile patients by sonohysterography, Hum. Reprod., 12, 487, 10.1093\u002Fhumrep\u002F12.3.487\nSchrager, 2004, Diethylstilbestrol exposure, Am. Fam. Physician., 69, 2395\nLitta, 2004, Hysteroscopic metroplasty under laparoscopic guidance in infertile women with septate uteri: follow-up of reproductive outcome, J. Reprod. Med., 49, 274\nKdous, 2003, Fertility after hysteroscopic treatment of intra-uterine adhesions, Gynecol. Obstet. Fertil., 31, 422, 10.1016\u002FS1297-9589(03)00101-2\nSchiano, 1999, The value of hysteroscopy after repeated implantation failures with in vitro fertilization, Contracept. Fertil. Sex., 27, 129\nFeghali, 2003, Systematic hysteroscopy prior to in vitro fertilization, Gynecol. Obstet Fertil., 31, 127\nSeneira, 1988, Hysteroscopy in an IVF-ER program, Acta Obstet. Gynecol. Scand., 67, 654\nLa Sala, 1985, Hysteroscopy and female sterility: analysis of the results from 213 patients, Acta Eur. Fertil., 16, 47\nShamma, 1992, The role of office hysteroscopy in in vitro fertilization, Fertil. Steril., 58, 1237, 10.1016\u002FS0015-0282(16)55576-9",{"ES":1296},"Utilidad de la histeroscopia diagnóstica en el estudio de la infertilidad",{"VOID":1298},"10.1016\u002Fs1283-081x(05)43391-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X05433913",[1301,1316,1328,1340,1352,1364],{"id":1302,"sortIndex":115,"researcher":26,"roles":1303,"affiliations":1304,"properties":1313},"d6dbd2e1-8558-4eac-a153-334c9e2c8fb1",[696],[1305],{"id":26,"sortIndex":36,"affiliation":1306,"properties":26},{"id":1307,"createTime":1308,"updateTime":1308,"relativeEntities":1309,"slug":26,"properties":1310,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"c372a8a2-1ab7-4b14-87b8-11b2ea4d64de","2023-12-13T13:35:41.742+00:00",[],{"title":1311},{"VI":1312},"Service de gynécologie obstétrique, hôpital La Conception, 147, boulevard Baille, Marseille 13005, France",{"title":1314},{"VI":1315},"F. Franchi",{"id":1317,"sortIndex":59,"researcher":26,"roles":1318,"affiliations":1319,"properties":1325},"cd449751-51dc-415e-84fe-71c7b6ee58d3",[696],[1320],{"id":26,"sortIndex":36,"affiliation":1321,"properties":26},{"id":1307,"createTime":1308,"updateTime":1308,"relativeEntities":1322,"slug":26,"properties":1323,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1324},{"VI":1312},{"title":1326},{"VI":1327},"V. Roger",{"id":1329,"sortIndex":111,"researcher":26,"roles":1330,"affiliations":1331,"properties":1337},"9290bb5b-fba7-4447-98f7-a095174ee880",[696],[1332],{"id":26,"sortIndex":36,"affiliation":1333,"properties":26},{"id":1307,"createTime":1308,"updateTime":1308,"relativeEntities":1334,"slug":26,"properties":1335,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1336},{"VI":1312},{"title":1338},{"VI":1339},"L. Cravello",{"id":1341,"sortIndex":36,"researcher":26,"roles":1342,"affiliations":1343,"properties":1349},"11aa1753-fcad-4bb2-b44d-0993f05ef7ae",[696],[1344],{"id":26,"sortIndex":36,"affiliation":1345,"properties":26},{"id":1307,"createTime":1308,"updateTime":1308,"relativeEntities":1346,"slug":26,"properties":1347,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1348},{"VI":1312},{"title":1350},{"VI":1351},"A. Agostini",{"id":1353,"sortIndex":162,"researcher":26,"roles":1354,"affiliations":1355,"properties":1361},"d18fbdec-9958-4c3d-8502-5a77de4309ee",[696],[1356],{"id":26,"sortIndex":36,"affiliation":1357,"properties":26},{"id":1307,"createTime":1308,"updateTime":1308,"relativeEntities":1358,"slug":26,"properties":1359,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1360},{"VI":1312},{"title":1362},{"VI":1363},"B. Blanc",{"id":1365,"sortIndex":114,"researcher":26,"roles":1366,"affiliations":1367,"properties":1373},"8be28c33-f4a2-4308-bbdc-282c87c480c5",[696],[1368],{"id":26,"sortIndex":36,"affiliation":1369,"properties":26},{"id":1307,"createTime":1308,"updateTime":1308,"relativeEntities":1370,"slug":26,"properties":1371,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1372},{"VI":1312},{"title":1374},{"VI":1375},"F. Bretelle",{"url":1299,"publisher":1377,"properties":1385},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1378,"slug":662,"properties":1379,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1382,"manageAffiliations":1383,"indexDatabases":1384,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1380,"title":1381},{"VOID":665},{"EN":667},[],[],[],{"volume":1386,"pages":1388},{"VOID":1387},"41",{"VOID":1389},"1-4","2005-01-01",2005,{"id":1393,"createTime":1394,"updateTime":1395,"relativeEntities":1396,"slug":1397,"properties":1398,"entityType":688,"verifyStatus":25,"verifyTime":1395,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1405,"fullTextUrl":26,"authors":1406,"publicationType":747,"publisherRelationship":1446,"citationCount":26,"citationInfo":26,"publishDate":1460,"publishYear":1461,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"efb0a041-615f-4e20-b346-1ea178210d32","2024-01-09T14:09:39.504+00:00","2025-02-23T17:47:43.208+00:00",[],"Embarazos-m%C3%BAltiples-estudio-anatomocl%C3%ADnico-y-tratamiento",{"references":1399,"title":1401,"doi":1403},{"VOID":1400},"Tandberg, 2010, Trends in incidence and mortality for triplets in Norway 1967-2006: the influence of assisted reproductive technologies, BJOG, 117, 667, 10.1111\u002Fj.1471-0528.2010.02530.x\nLuke, 2008, Maternal morbidity and infant death in twin vs triplet and quadruplet pregnancies, Am J Obstet Gynecol, 198, 10.1016\u002Fj.ajog.2007.10.785\nQuarello E, Ville Y. Syndrome transfuseur-transfusé : diagnostic et traitement. EMC (Elsevier Masson SAS, Paris), Obstétrique, 5-031-A-60, 2011.\nInstitut national d’études démographiques (INED). Accouchements multiples. www.ined.fr\u002Ffr\u002Ftout-savoir-population\u002Fchiffres\u002Ffrance\u002Fnaissance-fecondite\u002Faccouchements-multiples.\nSperling, 2007, Detection of chromosomal abnormalities, congenital abnormalities and transfusion syndrome in twins, Ultrasound Obstet Gynecol, 29, 517, 10.1002\u002Fuog.3918\nGlinianaia, 2008, Congenital anomalies in twins: a register-based study, Hum Reprod, 23, 1306, 10.1093\u002Fhumrep\u002Fden104\nGuilherme, 2009, Zygosity and chorionicity in triplet pregnancies: new data, Hum Reprod, 24, 100, 10.1093\u002Fhumrep\u002Fden364\nMachin, 1996, Zygosity and placental anatomy in 15 consecutive sets of spontaneously conceived triplets, Am J Med Genet, 61, 247, 10.1002\u002F(SICI)1096-8628(19960122)61:3\u003C247::AID-AJMG8>3.0.CO;2-R\nAgence de biomédecine. Le rapport médical et scientifique de l’Agence de la biomédecine 2015. Le rapport médical et scientifique de l’assistance médicale à la procréation et de la génétique humaines en France (tableau AMP3 : Inséminations, transferts d’embryons et accouchements multiples de 2011 à 2014). www.agence-biomedecine.fr.\nPison G. Près de la moitié des jumeaux naissent en Afrique. Population & Sociétés (INED). (n°360). Septembre 2000.\nPison G, Couvert N. La fréquence des accouchements gémellaires en France. La triple influence de la biologie, de la médecine et des comportements familiaux. In: Population, 59e année (n°6), 2004. p. 877-907.\nVan Mieghem, 2011, Fetal and maternal hemodynamics in pregnancy: new insights in the cardiovascular adaptation to uncomplicated pregnancy, twin-to-twin transfusion syndrome and congenital diaphragmatic hernia, Facts Views Vis Obgyn, 3, 205\nKametas, 2003, Maternal cardiac function in twin pregnancy, Obstet Gynecol, 102, 806\nKuleva, 2011, Maternal cardiac function in normal twin pregnancy: a longitudinal study, Ultrasound Obstet Gynecol, 38, 575, 10.1002\u002Fuog.8936\nGhi, 2015, Maternal cardiac evaluation during uncomplicated twin pregnancy with emphasis on the diastolic function, Am J Obstet Gynecol, 213, 10.1016\u002Fj.ajog.2015.05.003\nKrotz, 2002, Hypertensive disease in twin pregnancies: a review, Twin Res, 5, 8, 10.1375\u002Ftwin.5.1.8\nLučovnik, 2012, Risk factors for preeclampsia in twin pregnancies: a population-based matched case-control study, J Perinat Med, 40, 379, 10.1515\u002Fjpm-2011-0252\nFox, 2014, Risk factors for preeclampsia in twin pregnancies, Am J Perinatol, 31, 163\nUmadia, 2016, Preeclampsia in twin pregnancies, J Matern Fetal Neonatal Med, 29, 15, 10.1080\u002F14767058.2016.1234775\nCarter, 2015, The impact of chorionicity on maternal pregnancy outcomes, Am J Obstet Gynecol, 213, 390.e1-7, 10.1016\u002Fj.ajog.2015.05.027\nSparks, 2013, Does risk of preeclampsia differ by twin chorionicity?, J Matern Fetal Neonatal Med, 26, 1273, 10.3109\u002F14767058.2013.777701\nBartnik, 2016, Twin chorionicity and the risk of hypertensive disorders: gestational hypertension and pre-eclampsia, Twin Res Hum Genet, 19, 377, 10.1017\u002Fthg.2016.17\nCampbell, 1999, Preeclampsia in twin pregnancies: incidence and outcome, Hypertens Pregnancy, 18, 197, 10.3109\u002F10641959909016193\nSavvidou, 2001, Twin chorionicity and pre-eclampsia, Ultrasound Obstet Gynecol, 18, 228, 10.1046\u002Fj.0960-7692.2001.00470.x\nFoo, 2013, Characteristics of hypertensive disorders in twin versus singleton pregnancies, Pregnancy Hypertens, 3, 3, 10.1016\u002Fj.preghy.2012.05.005\nConnolly, 2016, Maternal clinical disease characteristics and maternal and neonatal outcomes in twin and singleton pregnancies with severe preeclampsia, Eur J Obstet Gynecol Reprod Biol, 201, 36, 10.1016\u002Fj.ejogrb.2015.11.031\nOsmundson, 2014, Maternal proteinuria in twin compared with singleton pregnancies, Obstet Gynecol, 124, 332, 10.1097\u002FAOG.0000000000000383\nLuo, 2006, Effect on neonatal outcomes in gestational hypertension in twin compared with singleton pregnancies, Obstet Gynecol, 108, 1138, 10.1097\u002F01.AOG.0000238335.61452.89\nSibai, 2000, Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units, Am J Obstet Gynecol, 182, 938, 10.1016\u002FS0002-9378(00)70350-4\nFox, 2014, The relationship between preeclampsia and intrauterine growth restriction in twin pregnancies, Am J Obstet Gynecol, 211, 10.1016\u002Fj.ajog.2014.05.035\nFerrazzani, 2015, Is gestational hypertension beneficial in twin pregnancies?, Pregnancy Hypertens, 5, 171, 10.1016\u002Fj.preghy.2015.01.003\nHehir, 2016, Gestational hypertensive disease in twin pregnancy: influence on outcomes in a large national prospective cohort, Aust N Z J Obstet Gynaecol, 56, 466, 10.1111\u002Fajo.12483\nSparks, 2017, Hypertension in dichorionic twin gestations: how is birthweight affected?, J Matern Fetal Neonatal Med, 30, 380, 10.3109\u002F14767058.2016.1174209\nPalei, 2013, Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology, Acta Physiol, 208, 224, 10.1111\u002Fapha.12106\nBdolah, 2008, Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?, Am J Obstet Gynecol, 198, 10.1016\u002Fj.ajog.2007.10.783\nFaupel-Badger, 2015, Maternal circulating angiogenic factors in twin and singleton pregnancies, Am J Obstet Gynecol, 212, 10.1016\u002Fj.ajog.2014.11.035\nRana, 2012, Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia, Hypertension, 60, 451, 10.1161\u002FHYPERTENSIONAHA.112.195065\nDröge, 2015, Maternal serum sFlt-1\u002FPlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies, Ultrasound Obstet Gynecol, 45, 286, 10.1002\u002Fuog.14760\nLai, 2016, Outcomes of singleton and twin pregnancies complicated by pre-existing diabetes and gestational diabetes: a population-based study in Alberta, Canada, 2005-11, J Diabetes, 8, 45, 10.1111\u002F1753-0407.12255\nMorikawa, 2015, Prevalence of hyperglycaemia in singleton versus twin pregnancy, Diabetes Metab Res Rev, 31, 198, 10.1002\u002Fdmrr.2586\nMcGrath, 2017, Outcomes of twin pregnancies complicated by gestational diabetes: a meta-analysis of observational studies, J Perinatol, 37, 360, 10.1038\u002Fjp.2016.254\nTward, 2016, Does gestational diabetes affect fetal growth and pregnancy outcome in twin pregnancies?, Am J Obstet Gynecol, 214, 10.1016\u002Fj.ajog.2015.11.006\nPoulain, 2015, Outcome of twin pregnancies associated with glucose intolerance, Diabetes Metab, 41, 387, 10.1016\u002Fj.diabet.2014.12.005\nD’Antonio, 2013, Early fetal loss in monochorionic and dichorionic twin pregnancies: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort, Ultrasound Obstet Gynecol, 41, 632, 10.1002\u002Fuog.12363\nKristiansen, 2015, Perinatal outcome after first-trimester risk assessment in monochorionic and dichorionic twin pregnancies: a population-based register study, BJOG, 122, 1362, 10.1111\u002F1471-0528.13326\nMahony, 2011, Fetal death in twins, Acta Obstet Gynecol Scand, 90, 1274, 10.1111\u002Fj.1600-0412.2011.01239.x\nRusso, 2013, Stillbirths in singletons, dichorionic and monochorionic twins: a comparison of risks and causes, Eur J Obstet Gynecol Reprod Biol, 170, 131, 10.1016\u002Fj.ejogrb.2013.06.014\nSouthwest Thames Obstetric Research Collaborative (STORK)., 2012, Prospective risk of late stillbirth in monochorionic twins: a regional cohort study, Ultrasound Obstet Gynecol, 39, 500, 10.1002\u002Fuog.11110\nVasak, 2017, Lower perinatal mortality in preterm born twins than in singletons: a nationwide study from The Netherlands, Am J Obstet Gynecol, 216, 10.1016\u002Fj.ajog.2016.10.005\nPage, 2015, The risk of stillbirth and infant death by each additional week of expectant management in twin pregnancies, Am J Obstet Gynecol, 212\nCheong-See, 2016, Prospective risk of stillbirth and neonatal complications in twin pregnancies: systematic review and meta-analysis, Br Med J, 354, i4353, 10.1136\u002Fbmj.i4353\nOng, 2002, The creation of twin centile curves for size, BJOG, 109, 753, 10.1111\u002Fj.1471-0528.2002.01361.x\nGielen, 2008, Twin-specific intrauterine ‘growth’ charts based on cross-sectional birthweight data, Twin Res Hum Genet, 11, 224, 10.1375\u002Ftwin.11.2.224\nStirrup, 2015, Fetal growth reference ranges in twin pregnancy: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort, Ultrasound Obstet Gynecol, 45, 301, 10.1002\u002Fuog.14640\nOdibo, 2013, Customized growth charts for twin gestations to optimize identification of small-for-gestational age fetuses at risk of intrauterine fetal death, Ultrasound Obstet Gynecol, 41, 637, 10.1002\u002Fuog.12404\nGhi, 2017, Società Italiana di Ecografia Ostetrica e Ginecologica working group on fetal biometric charts. development of customized fetal growth charts in twins, Am J Obstet Gynecol, 216, 514\nBreathnach, 2012, Fetal growth disorders in twin gestations, Semin Perinatol, 36, 175, 10.1053\u002Fj.semperi.2012.02.002\nMiller, 2012, Discordant twins: diagnosis, evaluation and management, Am J Obstet Gynecol, 206, 10, 10.1016\u002Fj.ajog.2011.06.075\nHalling, 2016, Neuro-developmental outcome of a large cohort of growth discordant twins, Eur J Pediatr, 175, 381, 10.1007\u002Fs00431-015-2648-8\nRoss, 2012, Physical growth and cognitive abilities in concordant versus discordant birth weight twins at three years old, Early Hum Dev, 88, 753, 10.1016\u002Fj.earlhumdev.2012.04.001\nBlickstein, 2003, Intertwin birth weight discordance as a potential adaptive measure to promote gestational age, J Reprod Med, 48, 449\nHartley, 2002, Size-discordant twin pairs have higher perinatal mortality rates than nondiscordant pairs, Am J Obstet Gynecol, 187, 1173, 10.1067\u002Fmob.2002.126961\nHarper, 2013, Significance of growth discordance in appropriately grown twins, Am J Obstet Gynecol, 208, 10.1016\u002Fj.ajog.2013.01.044\nLopriore, 2012, Placental characteristics in growth-discordant monochorionic twins: a matched case-control study, Placenta, 33, 171, 10.1016\u002Fj.placenta.2011.12.004\nFraser, 1994, Birthweight discordance, intrauterine growth retardation and perinatal outcomes in twins, J Reprod Med, 39, 504\nHsieh, 1994, Growth discordancy, birthweight and neonatal adverse events in third trimester twin gestations, Gynecol Obstet Invest, 38, 36, 10.1159\u002F000292442\nTalbot, 1997, Is size discordancy an indication for delivery of preterm twins?, Am J Obstet Gynecol, 177, 1050, 10.1016\u002FS0002-9378(97)70013-9\nConde-Agudelo, 2010, Transvaginal sonographic cervical length for the prediction of spontaneous preterm birth in twin pregnancies: a systematic review and metaanalysis, Am J Obstet Gynecol, 203, 10.1016\u002Fj.ajog.2010.02.064\nFuchs, 2016, Multiple gestations and preterm birth, Semin Fetal Neonatal Med, 21, 113, 10.1016\u002Fj.siny.2015.12.010\nKazemier, 2014, Impact of obstetric history on the risk of spontaneous preterm birth in singleton and multiple pregnancies: a systematic review, BJOG, 121, 1197, 10.1111\u002F1471-0528.12896\nFox, 2015, Gestational age at cervical length and fetal fibronectin assessment and the incidence of spontaneous preterm birth in twins, J Ultrasound Med, 34, 977, 10.7863\u002Fultra.34.6.977\nKindinger, 2016, The effect of gestational age and cervical length measurements in the prediction of spontaneous preterm birth in twin pregnancies: an individual patient level meta-analysis, BJOG, 123, 877, 10.1111\u002F1471-0528.13575\nStock, 2010, Preterm and term labour in multiple pregnancies, Semin Fetal Neonatal Med, 15, 10.1016\u002Fj.siny.2010.06.006\nLewi, 2013, The vascular anastomoses in monochorionic twin pregnancies and their clinical consequences, Am J Obstet Gynecol, 208, 19, 10.1016\u002Fj.ajog.2012.09.025\nKhalil, 2016, ISUOG Practice Guidelines: role of ultrasound in twin pregnancy, Ultrasound Obstet Gynecol, 47, 247, 10.1002\u002Fuog.15821\nEssaoui M, Chalouhi GE, Stirnemann J, Salomon LJ, Ville Y. Physiopathologie du syndrome transfuseur-transfusé et principes de prise en charge. EMC (Elsevier Masson SAS, Paris), Obstétrique, 5-031-A-50, 2015.\nEmery, 2016, North American Fetal Therapy Network: intervention vs expectant management for stage I twin-twin transfusion syndrome, Am J Obstet Gynecol, 215, 10.1016\u002Fj.ajog.2016.04.024\nRoberts, 2008, Interventions for twin-twin transfusion syndrome: a Cochrane review, Ultrasound Obstet Gynecol, 31, 701, 10.1002\u002Fuog.5328\nRoberts, 2014, Interventions for the treatment of twin-twin transfusion syndrome, Cochrane Database Syst Rev\nLopriore, 2007, Twin anemia-polycythemia sequence in two monochorionic twin pairs without oligopolyhydramnios sequence, Placenta, 28, 47, 10.1016\u002Fj.placenta.2006.01.010\nSananès, 2015, Evaluation of the utility of in utero treatment of twin anemia-polycythemia sequence, Fetal Diagn Ther, 38, 170, 10.1159\u002F000380822\nOng, 2006, Prognosis for the co-twin following single-twin death: a systematic review, BJOG, 113, 992, 10.1111\u002Fj.1471-0528.2006.01027.x\nVayssière, 2011, Twin pregnancies: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF), Eur J Obstet Gynecol Reprod Biol, 156, 12, 10.1016\u002Fj.ejogrb.2010.12.045\nKilby, 2016, Management of monochorionic twin pregnancy, BJOG, 124, e1\nGil, 2015, Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis, Ultrasound Obstet Gynecol, 45, 249, 10.1002\u002Fuog.14791\nEvans, 1999, Selective termination for structural, chromosomal, and mendelian anomalies: international experience, Am J Obstet Gynecol, 181, 893, 10.1016\u002FS0002-9378(99)70321-2\nRossi, 2009, Umbilical cord occlusion for selective feticide in complicated monochorionic twins: a systematic review of literature, Am J Obstet Gynecol, 200, 123, 10.1016\u002Fj.ajog.2008.08.039\nRoman, 2010, Selective reduction in complicated monochorionic pregnancies: radiofrequency ablation vs bipolar cord coagulation, Ultrasound Obstet Gynecol, 36, 37, 10.1002\u002Fuog.7567\nLanna, 2012, Bipolar cord coagulation for selective feticide in complicated monochorionic twin pregnancies: 118 consecutive cases at a single center, Ultrasound Obstet Gynecol, 39, 407, 10.1002\u002Fuog.11073\nYinon, 2015, Selective reduction in complicated monochorionic twins: prediction of obstetric outcome and comparison of techniques, Ultrasound Obstet Gynecol, 46, 670, 10.1002\u002Fuog.14879\nCrowther, 2010, Hospitalisation and bed rest for multiple pregnancy, Cochrane Database Syst Rev\nYamasmit, 2012, Prophylactic oral betamimetics for reducing preterm birth in women with a twin pregnancy, Cochrane Database Syst Rev, 9, 10.1002\u002F14651858.CD004733.pub3\nSchuit, 2015, Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis, BJOG, 122, 27, 10.1111\u002F1471-0528.13032\nSenat, 2013, Prevention of preterm delivery by 17 alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial, Am J Obstet Gynecol, 208\nRomero, 2017, Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data, Ultrasound Obstet Gynecol, 49, 303, 10.1002\u002Fuog.17397\nRebarber, 2014, Outcomes of emergency or physical examination-indicated cerclage in twin pregnancies compared to singleton pregnancies, Eur J Obstet Gynecol Reprod Biol, 173, 43, 10.1016\u002Fj.ejogrb.2013.11.016\nMiller, 2014, Outcomes after physical examination-indicated cerclage in twin gestations, Am J Obstet Gynecol, 211, 10.1016\u002Fj.ajog.2014.03.034\nRoman, 2016, Cerclage in twin pregnancy with dilated cervix between 16 to 24 weeks of gestation: retrospective cohort study, Am J Obstet Gynecol, 215, 10.1016\u002Fj.ajog.2016.01.172\nRoman, 2015, Efficacy of ultrasound-indicated cerclage in twin pregnancies, Am J Obstet Gynecol, 212, 10.1016\u002Fj.ajog.2015.01.031\nAllen, 2001, Management of monoamniotic twin pregnancies: a case series and systematic review of the litterature, BJOG, 108, 931\nPrefumo, 2015, The natural history of monoamniotic twin pregnancies: a case series and systematic review of the literature, Prenat Diagn, 35, 274, 10.1002\u002Fpd.4538\nHack, 2009, Perinatal outcome of monoamniotic twin pregnancies, Obstet Gynecol, 113, 353, 10.1097\u002FAOG.0b013e318195bd57\nDias, 2010, Cord entanglement and perinatal outcome in monoamniotic twin pregnancies, Ultrasound Obstet Gynecol, 35, 201, 10.1002\u002Fuog.7501\nRossi, 2013, Impact of cord entanglement on perinatal outcome of monoamniotic twins: a systematic review of the literature, Ultrasound Obstet Gynecol, 41, 131, 10.1002\u002Fuog.12345\nAnselem, 2015, Continued pregnancy and vaginal delivery after 32 weeks of gestation for monoamniotic twins, Eur J Obstet Gynecol Reprod Biol, 194, 194, 10.1016\u002Fj.ejogrb.2015.09.014\nMackenzie, 2002, The natural history of prenatally diagnosed conjoined twins, J Pediatr Surg, 37, 303, 10.1053\u002Fjpsu.2002.30830\nMorikawa, 2013, Clinical features and short term outcomes of triplet pregnancies in Japan, Int J Gynecol Obstet, 121, 86, 10.1016\u002Fj.ijgo.2012.10.022\nSkrablin, 2000, Maternal neonatal outcome in quadruplet and quintuplet versus triplet gestations, Eur J Obstet Gynecol Reprod Biol, 88, 147, 10.1016\u002FS0301-2115(99)00153-0\nChaveeva, 2013, Trichorionic and dichorionic triplet pregnancies at 10-14 weeks: outcome after embryo reduction compared to expectant management, Fetal Diagn Ther, 34, 199, 10.1159\u002F000356170",{"ES":1402},"Embarazos múltiples: estudio anatomoclínico y tratamiento",{"VOID":1404},"10.1016\u002Fs1283-081x(18)89342-0","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X18893420",[1407,1422,1434],{"id":1408,"sortIndex":114,"researcher":26,"roles":1409,"affiliations":1410,"properties":1419},"ede3ac76-92ae-4df5-ba49-5dead1b725c8",[696],[1411],{"id":26,"sortIndex":36,"affiliation":1412,"properties":26},{"id":1413,"createTime":1414,"updateTime":1414,"relativeEntities":1415,"slug":26,"properties":1416,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"84f9519c-edf3-4708-a354-2227b6e7389a","2024-01-09T14:09:39.554+00:00",[],{"title":1417},{"VI":1418},"Maternité Alix-de-Champagne, Hôpital Maison-Blanche, Université de Reims et CHU de Reims, 45, rue Cognacq-Jay, 51092 Reims cedex, France",{"title":1420},{"VI":1421},"J. Burette",{"id":1423,"sortIndex":115,"researcher":26,"roles":1424,"affiliations":1425,"properties":1431},"006a9a1f-458a-4b46-958c-22ea7e1d3bef",[696],[1426],{"id":26,"sortIndex":36,"affiliation":1427,"properties":26},{"id":1413,"createTime":1414,"updateTime":1414,"relativeEntities":1428,"slug":26,"properties":1429,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1430},{"VI":1418},{"title":1432},{"VI":1433},"S. Bonneau",{"id":1435,"sortIndex":36,"researcher":26,"roles":1436,"affiliations":1437,"properties":1443},"4211cd42-64bc-4339-a006-d24d126cbcb3",[696],[1438],{"id":26,"sortIndex":36,"affiliation":1439,"properties":26},{"id":1413,"createTime":1414,"updateTime":1414,"relativeEntities":1440,"slug":26,"properties":1441,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1442},{"VI":1418},{"title":1444},{"VI":1445},"R. Gabriel",{"url":1405,"publisher":1447,"properties":1455},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1448,"slug":662,"properties":1449,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1452,"manageAffiliations":1453,"indexDatabases":1454,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1450,"title":1451},{"VOID":665},{"EN":667},[],[],[],{"volume":1456,"pages":1458},{"VOID":1457},"54",{"VOID":1459},"1-16","2018-06-01",2018,{"id":1463,"createTime":1464,"updateTime":1464,"relativeEntities":1465,"slug":26,"properties":1466,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1473,"fullTextUrl":26,"authors":1474,"publicationType":747,"publisherRelationship":1526,"citationCount":26,"citationInfo":26,"publishDate":1538,"publishYear":765,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"e79e628b-a5ca-434e-bd2e-d3bebf37e770","2024-02-11T23:41:12.037+00:00",[],{"references":1467,"title":1469,"doi":1471},{"VOID":1468},"Cantwell, 2011, Saving mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom, BJOG, 118, 1\nRoyal College of Obstetricians and Gynaecologists. Antepartum haemorrhage. Green-top guidelines 2011;(n°63).\nSaucedo, 2013, Maternal mortality in France, 2007-2009, J Gynecol Obstet Biol Reprod, 42, 613, 10.1016\u002Fj.jgyn.2013.06.011\nKayem, 2014, Management of placenta previa and accreta, J Gynecol Obstet Biol Reprod, 43, 1142, 10.1016\u002Fj.jgyn.2014.10.007\nSentilhes, 2014, Postpartum hemorrhage: guidelines for clinical practice - text of the guidelines (short text), J Gynecol Obstet Biol Reprod, 43, 1170, 10.1016\u002Fj.jgyn.2014.10.009\nGoffinet, 2003, Hémorragies obstétricales du postpartum, 932\nAl Kadri, 2011, Visual estimation versus gravimetric measurement of postpartum blood loss: a prospective cohort study, Arch Gynecol Obstet, 283, 1207, 10.1007\u002Fs00404-010-1522-1\nPatel, 2006, Drape estimation vs. visual assessment for estimating postpartum hemorrhage, Int J Gynaecol Obstet, 93, 220, 10.1016\u002Fj.ijgo.2006.02.014\nToledo, 2007, The accuracy of blood loss estimation after simulated vaginal delivery, Anesth Analg, 105, 1736, 10.1213\u002F01.ane.0000286233.48111.d8\nInVS; IdvsRdCNdEslMMC-jP. www.invs.sante.fr. 2010.\nDarlington, 2012, Effects of in vitro hemodilution, hypothermia and rFVIIa addition on coagulation in human blood, Int J Burns Trauma, 2, 42\nJude, 2004, Hémostase et hypothermie, Sang Thromb Vaiss, 16, 515\nMcLintock, 2011, Obstetric hemorrhage, J Thromb Haemost, 9, 1441, 10.1111\u002Fj.1538-7836.2011.04398.x\nGoffinet, 1995, Practical use of sulprostone in the treatment of hemorrhages during delivery, J Gynecol Obstet Biol Reprod, 24, 209\nRaynal, 2011, Bakri balloon, Gynecol Obstet Fertil, 39, 438, 10.1016\u002Fj.gyobfe.2011.04.001\nBakri, 2001, Tamponade-balloon for obstetrical bleeding, Int J Gynaecol Obstet, 74, 139, 10.1016\u002FS0020-7292(01)00395-2\nVitthala, 2009, Use of Bakri balloon in post-partum haemorrhage: a series of 15 cases, Aust N Z J Obstet Gynaecol, 49, 191, 10.1111\u002Fj.1479-828X.2009.00968.x\nRoyal College of Obstetricians Gynaecologists, 2009\nLeduc, 2009, Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage, J Obstet Gynaecol Can, 31, 980, 10.1016\u002FS1701-2163(16)34329-8\nACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists number 76, October 2006: postpartum hemorrhage. Obstet Gynecol 2006; 108:1039–47.\nLalonde, 2006, Postpartum hemorrhage today: ICM\u002FFIGO initiative 2004-2006, Int J Gynaecol Obstet, 94, 243, 10.1016\u002Fj.ijgo.2006.04.016\nAya, 2014, Anesthetic management of severe or worsening postpartum hemorrhage, J Gynecol Obstet Biol Reprod, 43, 1030, 10.1016\u002Fj.jgyn.2014.10.001\nReccommandations pour la pratique clinique. Hémorragies du postpartum immédiat. J Gynecol Obstet Biol Reprod 2004; 33(Suppl. 8).\nBorgman, 2007, The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital, J Trauma, 63, 805, 10.1097\u002FTA.0b013e3181271ba3\nSher, 1977, Pathogenesis and management of uterine inertia complicating abruptio placentae with consumption coagulopathy, Am J Obstet Gynecol, 129, 164, 10.1016\u002F0002-9378(77)90739-6\nHolcomb, 2008, Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients, Ann Surg, 248, 447, 10.1097\u002FSLA.0b013e318185a9ad\nLevy, 2014, Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy, Transfusion, 54, 1389, 10.1111\u002Ftrf.12431\nHiippala, 1995, Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates, Anesth Analg, 81, 360\nHossain, 2010, Disseminated intravascular coagulation, 394\nCharbit, 2007, The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage, J Thromb Haemost, 5, 266, 10.1111\u002Fj.1538-7836.2007.02297.x\nCortet, 2012, Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial, Br J Anaesth, 108, 984, 10.1093\u002Fbja\u002Faes096\nWikkelso, 2015, Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial, Br J Anaesth, 114, 623, 10.1093\u002Fbja\u002Faeu444\nBell, 2010, The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage, Int J Obstet Anesth, 19, 218, 10.1016\u002Fj.ijoa.2009.08.004\nWatson, 2009, Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome, J Trauma, 67, 221, 10.1097\u002FTA.0b013e3181ad5957\nDucloy-Bouthors, 2011, High-dose tranexamic acid reduces blood loss in postpartum haemorrhage, Crit Care, 15, R117, 10.1186\u002Fcc10143\nGungorduk, 2011, Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study, Am J Perinatol, 28, 233, 10.1055\u002Fs-0030-1268238\nMovafegh, 2011, Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery, Int J Gynaecol Obstet, 115, 224, 10.1016\u002Fj.ijgo.2011.07.015\nShakur, 2010, The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial, Trials, 11, 40, 10.1186\u002F1745-6215-11-40\nAhonen, 2007, An open non-randomized study of recombinant activated factor VII in major postpartum haemorrhage, Acta Anaesthesiol Scand, 51, 929, 10.1111\u002Fj.1399-6576.2007.01323.x\nAlfirevic, 2007, Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004, Obstet Gynecol, 110, 1270, 10.1097\u002F01.AOG.0000288515.48066.99\nPhillips, 2009, Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry, Anesth Analg, 109, 1908, 10.1213\u002FANE.0b013e3181c039e6\nMannucci, 2007, Prevention and treatment of major blood loss, N Engl J Med, 356, 2301, 10.1056\u002FNEJMra067742\nMcMorrow, 2008, Use of recombinant factor VIIa in massive post-partum haemorrhage, Eur J Anaesthesiol, 25, 293, 10.1017\u002FS0265021507003109\nLe Gouez, 2011, Hémorragie du postpartum, 1\nHuissoud, 2009, Coagulation assessment by rotation thrombelastometry in normal pregnancy, Thromb Haemost, 101, 755, 10.1160\u002FTH08-06-0386\nJohansson, 2009, Thrombelastography and tromboelastometry in assessing coagulopathy in trauma, Scand J Trauma, 17, 45\nOudghiri, 2011, Reference values for rotation thromboelastometry (ROTEM(R)) parameters following non-haemorrhagic deliveries. Correlations with standard haemostasis parameters, Thromb Haemost, 106, 176, 10.1160\u002FTH11-02-0058",{"ES":1470},"Hemorragias obstétricas",{"VOID":1472},"10.1016\u002Fs1283-081x(20)44038-x","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X2044038X",[1475,1490,1502,1514],{"id":1476,"sortIndex":115,"researcher":26,"roles":1477,"affiliations":1478,"properties":1487},"4274695b-f6da-4fcd-b236-44030f5a36ad",[696],[1479],{"id":26,"sortIndex":36,"affiliation":1480,"properties":26},{"id":1481,"createTime":1482,"updateTime":1482,"relativeEntities":1483,"slug":26,"properties":1484,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"53aeca03-5a15-4fa3-9f57-d17563997a00","2024-02-11T23:41:12.073+00:00",[],{"title":1485},{"VI":1486},"Service d’anesthésie, CHU Louis-Mourier, AP–HP, Université Paris-7, 178, rue des Renouillers, 92701 Colombes cedex, France",{"title":1488},{"VI":1489},"S. Nebout",{"id":1491,"sortIndex":114,"researcher":26,"roles":1492,"affiliations":1493,"properties":1499},"2276735c-c0b1-4135-bf31-ae1b54c85d18",[696],[1494],{"id":26,"sortIndex":36,"affiliation":1495,"properties":26},{"id":1481,"createTime":1482,"updateTime":1482,"relativeEntities":1496,"slug":26,"properties":1497,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1498},{"VI":1486},{"title":1500},{"VI":1501},"J. Filippov",{"id":1503,"sortIndex":59,"researcher":26,"roles":1504,"affiliations":1505,"properties":1511},"709705e1-705a-40e3-a636-914bf753774a",[696],[1506],{"id":26,"sortIndex":36,"affiliation":1507,"properties":26},{"id":1481,"createTime":1482,"updateTime":1482,"relativeEntities":1508,"slug":26,"properties":1509,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1510},{"VI":1486},{"title":1512},{"VI":1513},"H. Keita",{"id":1515,"sortIndex":36,"researcher":26,"roles":1516,"affiliations":1517,"properties":1523},"0a5cb27e-d316-4a2b-8698-6a437678bbdf",[696],[1518],{"id":26,"sortIndex":36,"affiliation":1519,"properties":26},{"id":1481,"createTime":1482,"updateTime":1482,"relativeEntities":1520,"slug":26,"properties":1521,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1522},{"VI":1486},{"title":1524},{"VI":1525},"L. Ossé",{"url":1473,"publisher":1527,"properties":1535},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1528,"slug":662,"properties":1529,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1532,"manageAffiliations":1533,"indexDatabases":1534,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1530,"title":1531},{"VOID":665},{"EN":667},[],[],[],{"volume":1536,"pages":1537},{"VOID":759},{"VOID":933},"2020-08-01",{"id":1540,"createTime":1541,"updateTime":1541,"relativeEntities":1542,"slug":26,"properties":1543,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1550,"fullTextUrl":26,"authors":1551,"publicationType":747,"publisherRelationship":1567,"citationCount":26,"citationInfo":26,"publishDate":1581,"publishYear":1582,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"5a756726-a24c-4418-bd99-1085b02f73c6","2024-01-10T12:38:16.596+00:00",[],{"references":1544,"title":1546,"doi":1548},{"VOID":1545},"Tavassoli, 2003, Tumours of the ovary, 113\nRay-Coquard I, Pujade-Lauraine E, Pautier P, Méeus P, Morice P, Treilleux I, et al. Tumeurs rares de l’ovaire : stratégies thérapeutiques et organisation de la prise en charge. EMC (Elsevier Masson SAS, Paris), Gynécologie, 680-A-50, 2011.\nMcCluggage, 2010, The pathology of and controversial aspects of ovarian borderline tumours, Curr Opin Oncol, 22, 462, 10.1097\u002FCCO.0b013e32833b0dc1\nKurman, 2005, Serous borderline tumours of the ovary, Histopathology, 47, 310, 10.1111\u002Fj.1365-2559.2005.02186.x\nChang, 2008, Prognostic significance of the micropapillary pattern in patients with serous ovarian tumors, Acta Obstet Gynecol Scand, 87, 476, 10.1080\u002F00016340801995640\nUzan, 2011, Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary, Oncologist, 16, 189, 10.1634\u002Ftheoncologist.2009-0139\nSeidman, 2000, Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators, Hum Pathol, 31, 539, 10.1053\u002Fhp.2000.8048\nRao, 2004, Surgical staging of ovarian low malignant potential tumors, Obstet Gynecol, 104, 261, 10.1097\u002F01.AOG.0000133484.92629.88\nLongacre, 2005, Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or=5-year) follow-up, Am J Surg Pathol, 29, 707, 10.1097\u002F01.pas.0000164030.82810.db\nLesieur, 2011, Prognostic value of lymph node involvement in ovarian serous borderline tumors, Am J Obstet Gynecol, 204, 10.1016\u002Fj.ajog.2010.12.055\nKanat-Pektas, 2011, Complete lymph node dissection: is it essential for the treatment of borderline epithelial ovarian tumors?, Arch Gynecol Obstet, 283, 879, 10.1007\u002Fs00404-010-1539-5\nMcKenney, 2006, Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification, Am J Surg Pathol, 30, 614, 10.1097\u002F01.pas.0000194743.33540.e6\nDjordjevic, 2010, Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases, Am J Surg Pathol, 34, 1, 10.1097\u002FPAS.0b013e3181c0a5ab\nFadare, 2009, Recent developments on the significance and pathogenesis of lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors), Int J Gynecol Cancer, 19, 103, 10.1111\u002FIGC.0b013e3181991a49\nSilverberg, 2000, Histopathologic grading of ovarian carcinoma: a review and proposal, Int J Gynecol Pathol, 19, 7, 10.1097\u002F00004347-200001000-00003\nMalpica, 2004, Grading ovarian serous carcinoma using a two-tier system, Am J Surg Pathol, 28, 496, 10.1097\u002F00000478-200404000-00009\nVang, 2009, Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems, Adv Anat Pathol, 16, 267, 10.1097\u002FPAP.0b013e3181b4fffa\nGilks, 2009, Ovarian carcinoma pathology and genetics: recent advances, Hum Pathol, 40, 1213, 10.1016\u002Fj.humpath.2009.04.017\nMalpica, 2007, Inter-observer and intra-observer variability of a two-tier system for grading ovarian serous carcinoma, Am J Surg Pathol, 31, 1203, 10.1097\u002FPAS.0b013e31803199b0\nVang, 2008, Subdividing ovarian and peritoneal serous carcinoma into moderately- and poorly-differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data, Am J Surg Pathol, 32, 1667, 10.1097\u002FPAS.0b013e31816fd555\nKindelberger, 2007, Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship, Am J Surg Pathol, 31, 161, 10.1097\u002F01.pas.0000213335.40358.47\nPal, 2005, BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases, Cancer, 104, 2807, 10.1002\u002Fcncr.21536\nRish, 2001, Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer, Am J Hum Genet, 68, 700, 10.1086\u002F318787\nLerwill, 2008, Mucinous tumours of the ovary, Diagn Histopathol, 14, 366, 10.1016\u002Fj.mpdhp.2008.06.010\nRodriguez, 2002, Mucinous tumors of the ovary. A clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas, Am J Surg Pathol, 26, 139, 10.1097\u002F00000478-200202000-00001\nProvenza, 2008, Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcoma-like mural nodules, Am J Surg Pathol, 32, 383, 10.1097\u002FPAS.0b013e3181451b93\nRonnett, 1997, Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women, Int J Gynecol Pathol, 16, 1, 10.1097\u002F00004347-199701000-00001\nKim, 2010, Endocervical-like (Mullerian) mucinous borderline tumours of the ovary frequently associated with KRAS mutation, Histopathology, 57, 587, 10.1111\u002Fj.1365-2559.2010.03673.x\nMcMeekin, 1995, Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis, Gynecol Oncol, 59, 81, 10.1006\u002Fgyno.1995.1271\nPetterson, 1991\nWu, 2007, Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt\u002FB-catenin and PI3K\u002FPten signaling pathways, Cancer Cell, 11, 321, 10.1016\u002Fj.ccr.2007.02.016\nKurman, 2011, Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm, Hum Pathol, 42, 918, 10.1016\u002Fj.humpath.2011.03.003\nCho, 2009, Ovarian cancer, Annu Rev Pathol, 4, 287, 10.1146\u002Fannurev.pathol.4.110807.092246\nWiegand, 2010, ARID1A mutations in endometriosis-associated ovarian carcinomas, N Engl J Med, 363, 1532, 10.1056\u002FNEJMoa1008433\nCatasus, 2004, Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas, Hum Pathol, 35, 1360, 10.1016\u002Fj.humpath.2004.07.019\nEichhorn, 2002, Mesodermal (mullerian) adenosarcoma of the ovary: a clinic-pathologic analysis of 40 cases and a review of the literature, Am J Surg Pathol, 26, 1243, 10.1097\u002F00000478-200210000-00001\nOliva, 2007, CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases, Int J Gynecol Pathol, 26, 359, 10.1097\u002FPGP.0b013e318064511c\nDeLair, 2011, Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases, Am J Surg Pathol, 35, 36, 10.1097\u002FPAS.0b013e3181ff400e\nMcCluggage, 2008, My approach to and thoughts on the typing of ovarian carcinomas, J Clin Pathol, 61, 152, 10.1136\u002Fjcp.2007.049478\nPrat, 2005, Hereditary ovarian cancer, Hum Pathol, 36, 861, 10.1016\u002Fj.humpath.2005.06.006\nCuatrecasas, 2009, Transitional cell tumors of the ovary. A comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas, Am J Surg Pathol, 33, 556, 10.1097\u002FPAS.0b013e318188b84c\nAl-Agha, 2011, FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary, Am J Surg Pathol, 35, 484, 10.1097\u002FPAS.0b013e31820a406c\nShah, 2009, Mutation of FOXL2 in granulosa-cell tumors of the ovary, N Engl J Med, 360, 2719, 10.1056\u002FNEJMoa0902542\nD’Angelo, 2011, Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary, Mod Pathol, 24, 1360, 10.1038\u002Fmodpathol.2011.95\nRoth, 2011, Perspectives on pure ovarian stromal neoplasms and tumor-like proliferations of the ovarian stroma, Am J Surg Pathol, 35, e15, 10.1097\u002FPAS.0b013e31820acb89\nYoung, 1985, Ovarian Sertoli-Leydig cell tumor. A clinicopathological analysis of 207 cases, Am J Surg Pathol, 9, 543, 10.1097\u002F00000478-198508000-00001\nZhao, 2009, Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors, Am J Surg Pathol, 33, 354, 10.1097\u002FPAS.0b013e318188373d\nRoth, 2006, Recent advances in the pathology and classification of ovarian germ cell tumors, Int J Gynecol Pathol, 25, 305, 10.1097\u002F01.pgp.0000225844.59621.9d\nScully, 1998\nKleinman, 1993, Primary neuroectodermal tumours of the ovary. A report of 25 cases, Am J Surg Pathol, 17, 764, 10.1097\u002F00000478-199308000-00002\nBuenerd, 2006, Neuroblastome ovarien, Bull Div Fr AIP, 98\nTalerman, 2011, Germ cell tumors of the ovary\nCao, 2009, SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell, Am J Surg Pathol, 33, 894, 10.1097\u002FPAS.0b013e318198177d",{"ES":1547},"Clasificación histopatológica de los tumores ováricos",{"VOID":1549},"10.1016\u002Fs1283-081x(14)68443-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X14684435",[1552],{"id":1553,"sortIndex":36,"researcher":26,"roles":1554,"affiliations":1555,"properties":1564},"81e595b1-578f-4e41-a9f2-20a3d5fde68e",[696],[1556],{"id":26,"sortIndex":36,"affiliation":1557,"properties":26},{"id":1558,"createTime":1559,"updateTime":1559,"relativeEntities":1560,"slug":26,"properties":1561,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"7ccd6337-c0b8-480e-8767-eaf4ebcf4345","2024-01-10T12:38:16.607+00:00",[],{"title":1562},{"VI":1563},"Service d’anatomie pathologique, Hôpital européen Georges-Pompidou, 20, rue Leblanc, 75508 Paris cedex 15, France",{"title":1565},{"VI":1566},"M.-A. Le Frère-Belda",{"url":1550,"publisher":1568,"properties":1576},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1569,"slug":662,"properties":1570,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1573,"manageAffiliations":1574,"indexDatabases":1575,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1571,"title":1572},{"VOID":665},{"EN":667},[],[],[],{"volume":1577,"pages":1579},{"VOID":1578},"50",{"VOID":1580},"1-24","2014-09-01",2014,{"id":1584,"createTime":1585,"updateTime":1586,"relativeEntities":1587,"slug":1588,"properties":1589,"entityType":688,"verifyStatus":25,"verifyTime":1586,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1596,"fullTextUrl":26,"authors":1597,"publicationType":747,"publisherRelationship":1697,"citationCount":26,"citationInfo":26,"publishDate":1710,"publishYear":1711,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"b0a27278-2198-49bf-ac35-0a226cc40ad1","2023-12-27T23:31:41.475+00:00","2025-02-11T23:13:03.372+00:00",[],"T%C3%A9cnicas-quir%C3%BArgicas-de-cerclaje-del-cuello-uterino",{"references":1590,"title":1592,"doi":1594},{"VOID":1591},"Harger, 1983, Cervical cerclage: patient selection, morbidity, and success rates, Clin Perinatol, 10, 321, 10.1016\u002FS0095-5108(18)30969-2\nHermann, 1902, Notes on Emet's operation as a prevention of abortion, J Obstet Gynaecol Br Commonw, 2, 256, 10.1111\u002Fj.1471-0528.1902.tb15022.x\nHarger, 1980, Comparison of success and morbidity in cervical cerclage procedures, Obstet Gynecol, 56, 543\nLidegaard, 1994, Cervical incompetence and cerclage in Denmark 1980-1990. A register based epidemiological survey, Acta Obstet Gynecol Scand, 73, 35, 10.3109\u002F00016349409013390\nLang, 1996, A comparison of risk factors for preterm labor and term small-for-gestational-age birth, Epidemiology, 7, 369, 10.1097\u002F00001648-199607000-00006\nLazar, 1979, Comparison of two successive policies of cervical cerclage for the prevention of pre-term birth, Eur J Obstet Gynecol Reprod Biol, 9, 307, 10.1016\u002F0028-2243(79)90080-7\nMcDonald, 1957, Suture of the cervix for inevitable miscarriage, J Obstet Gynaecol Br Emp, 64, 346, 10.1111\u002Fj.1471-0528.1957.tb02650.x\nPapiernik-Berkauer, 1978, 103\nBrunner, 1966, Roentgenologic changes in uterine isthmus insufficiency, Am J Roentgenol Radium Ther Nucl Med, 98, 239, 10.2214\u002Fajr.98.1.239\nBerghella, 1999, Prediction of preterm delivery with transvaginal ultrasonography of the cervix in patients with high-risk pregnancies: does cerclage prevent prematurity?, Am J Obstet Gynecol, 181, 809, 10.1016\u002FS0002-9378(99)70306-6\nGomez, 1994, Ultrasonographic examination of the uterine cervix is better than cervical digital examination as a predictor of the likelihood of premature delivery in patients with preterm labor and intact membranes, Am J Obstet Gynecol, 171, 956, 10.1016\u002F0002-9378(94)90014-0\nGuzman, 1998, Pregnancy outcomes in women treated with elective versus ultrasound-indicated cervical cerclage, Ultrasound Obstet Gynecol, 12, 323, 10.1046\u002Fj.1469-0705.1998.12050323.x\nIams, 1994, Cervical sonography in preterm labor, Obstet Gynecol, 84, 40\nLash, 1960, The incompetent internal os of the cervix: diagnosis and treatment, Am J Obstet Gynecol, 79, 552, 10.1016\u002F0002-9378(60)90256-8\nShirodkar, 1955, A new method for operative treatment of habitual abortions in the second trimester of pregnancy, Antiseptic, 52, 299\nDubuisson, 2008, How I perform a laparoscopic transabdominal isthmic cerclage, Gynecol Obstet Fertil, 36, 459, 10.1016\u002Fj.gyobfe.2008.02.018\nBenson, 1965, Transabdominal cervico uterine cerclage during pregnancy for the treatment of cervical incompetency, Obstet Gynecol, 25, 145\nDeffieux, 2006, Transvaginal cervico-isthmic cerclage using polypropylene tape: surgical procedure and pregnancy outcome: Fernandez's procedure, J Gynecol Obstet Biol Reprod, 35, 465, 10.1016\u002FS0368-2315(06)76418-3\nHervet, 1959, Purse-string suturing of the isthmus in cervicectomized patients, Bull Fed Soc Gynecol Obstet Lang Fr, 11, 445\nFuchs, 2008, Cervical cerclage in 2008, Gynecol Obstet Fertil, 36, 1074, 10.1016\u002Fj.gyobfe.2008.07.013\nToaff, 1974, Diagnosis of impending late abortion, Obstet Gynecol, 43, 756\nLash, 1950, Habitual abortion; the incompetent internal os of the cervix, Am J Obstet Gynecol, 59, 68, 10.1016\u002F0002-9378(50)90342-5\nAlthuisius, 2001, Final results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone, Am J Obstet Gynecol, 185, 1106, 10.1067\u002Fmob.2001.118655\nRCOG Final report of the Medical Research Council\u002FRoyal College of Obstetricians and Gynaecologists multicentre randomized trial of cervical cerclage MRC\u002FRCOG Working Party on Cervical Cerclage. Br J Obstet Gynaecol 1993; 100:516–23.\nWoensdregt, 2008, Effect of 2 stitches vs 1 stitch on the prevention of preterm birth in women with singleton pregnancies who undergo cervical cerclage, Am J Obstet Gynecol, 198, 396e1, 10.1016\u002Fj.ajog.2007.10.782\nBerghella, 2004, Cerclage for prevention of preterm birth in women with a short cervix found on transvaginal ultrasound examination: a randomized trial, Am J Obstet Gynecol, 191, 1311, 10.1016\u002Fj.ajog.2004.06.054\nRust, 2000, A randomized trial of cerclage versus no cerclage among patients with ultrasonographically detected second-trimester preterm dilatation of the internal os, Am J Obstet Gynecol, 183, 830, 10.1067\u002Fmob.2000.109040\nTo, 2004, Cervical cerclage for prevention of preterm delivery in women with short cervix: randomised controlled trial, Lancet, 363, 1849, 10.1016\u002FS0140-6736(04)16351-4\nBerghella, 2005, Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data, Obstet Gynecol, 106, 181, 10.1097\u002F01.AOG.0000168435.17200.53\nDebby, 2007, Favorable outcome following emergency second trimester cerclage, Int J Gynaecol Obstet, 96, 16, 10.1016\u002Fj.ijgo.2006.09.002\nMorin, 1997, Emergency cerclage for prevention of second trimester loss, Am J Obstet Gynecol, 176, S147, 10.1016\u002FS0002-9378(97)80576-5\nNovy, 2001, Cervical cerclage in the second trimester of pregnancy: a historical cohort study, Am J Obstet Gynecol, 184, 1447, 10.1067\u002Fmob.2001.114854\nPereira, 2007, Expectant management compared with physical examination-indicated cerclage (EM-PEC) in selected women with a dilated cervix at 14(0\u002F7)-25(6\u002F7) weeks: results from the EM-PEC international cohort study, Am J Obstet Gynecol, 197, 483e1, 10.1016\u002Fj.ajog.2007.05.041\nStupin, 2008, Emergency cerclage versus bed rest for amniotic sac prolapse before 27 gestational weeks. A retrospective, comparative study of 161 women, Eur J Obstet Gynecol Reprod Biol, 139, 32, 10.1016\u002Fj.ejogrb.2007.11.009\nDaskalakis, 2006, Management of cervical insufficiency and bulging fetal membranes, Obstet Gynecol, 107, 221, 10.1097\u002F01.AOG.0000187896.04535.e6\nOlatunbosun, 1995, Emergency cerclage compared with bed rest for advanced cervical dilatation in pregnancy, Int Surg, 80, 170\nAlthuisius, 2003, Cervical incompetence prevention randomized cerclage trial: emergency cerclage with bed rest versus bed rest alone, Am J Obstet Gynecol, 189, 907, 10.1067\u002FS0002-9378(03)00718-X\nDebbs, 2007, Transabdominal cerclage after comprehensive evaluation of women with previous unsuccessful transvaginal cerclage, Am J Obstet Gynecol, 197, 317e1, 10.1016\u002Fj.ajog.2007.06.060\nLotgering, 2006, Outcome after transabdominal cervicoisthmic cerclage, Obstet Gynecol, 107, 779, 10.1097\u002F01.AOG.0000206817.97328.cd\nNovy, 1991, Transabdominal cervicoisthmic cerclage: a reappraisal 25 years after its introduction, Am J Obstet Gynecol, 164, 1635, 10.1016\u002F0002-9378(91)91448-6\nZaveri, 2002, Abdominal versus vaginal cerclage after a failed transvaginal cerclage: a systematic review, Am J Obstet Gynecol, 187, 868, 10.1067\u002Fmob.2002.126959\nDeffieux, 2006, Novel application of polypropylene sling: transvaginal cervicoisthmic cerclage in women with high risk of preterm delivery, J Minim Invasive Gynecol, 13, 216, 10.1016\u002Fj.jmig.2006.01.005\nGolfier, 2001, Transvaginal cervicoisthmic cerclage as an alternative to the transabdominal technique, Eur J Obstet Gynecol Reprod Biol, 100, 16, 10.1016\u002FS0301-2115(01)00444-4\nKatz, 2005, Transvaginal placement of cervicoisthmic cerclage: report on pregnancy outcome, Am J Obstet Gynecol, 192, 1989, 10.1016\u002Fj.ajog.2005.02.127\nFrydman, 1983, Cerclage du col utérin sans anesthésie, Contracept Fertil Sex, 11, 639\nGervaise A, Senat MV, Ville Y, Fernandez H. Techniques de cerclage du col utérin. EMC (Elsevier Masson SAS, Paris), Techniques chirurgicales - Gynécologie, 41-895, 2000 : 7p.\nNovy, 1982, Transabdominal cervicoisthmic cerclage for the management of repetitive abortion and premature delivery, Am J Obstet Gynecol, 143, 44, 10.1016\u002F0002-9378(82)90682-2\nPage, 1958, Incompetent internal os of the cervix causing late abortion and premature labor; technic for surgical repair, Obstet Gynecol, 12, 509\nParikh, 1961, Internal cervical os during the second half of pregnancy, J Obstet Gynaecol Br Emp, 68, 818, 10.1111\u002Fj.1471-0528.1961.tb02817.x\nRozenberg, 2003, Comparison of two methods of cervical cerclage by ultrasound cervical measurement, J Matern Fetal Neonatal Med, 13, 314, 10.1080\u002Fjmf.13.5.314.317\nParisi, 1988, Cervical incompetence and preterm labor, Clin Obstet Gynecol, 31, 585, 10.1097\u002F00003081-198809000-00007\nHolman, 1973, An aid for cervical cerclage, Obstet Gynecol, 42, 468\nGoodlin, 1979, Cervical incompetence, hourglass membranes, and amniocentesis, Obstet Gynecol, 54, 748\nTsatsaris, 2001, Balloon replacement of fetal membranes to facilitate emergency cervical cerclage, Obstet Gynecol, 98, 243\nMann, 1961, The physiology and clinical significance of the uterine isthmus. I. The two-stage intrauterine ballon in the diagnosis and treatment of cervical incompetence, Am J Obstet Gynecol, 81, 209, 10.1016\u002FS0002-9378(16)36356-6\nGervaise, 2000, Cervical cerclage with buried prosthetic band: technique, indications and results in a series of 28 pregnancies, J Gynecol Obstet Biol Reprod, 29, 579\nCohen, 2008, How I perform a laparoscopic cervicoisthmic cerclage, Gynecol Obstet Fertil, 36, 457, 10.1016\u002Fj.gyobfe.2008.02.019\nBarter, 1958, Surgical closure of the incompetent cervix during pregnancy, Am J Obstet Gynecol, 75, 511, 10.1016\u002F0002-9378(58)90608-2\nOlatunbosun, 1981, Cervical cerclage operation for a dilated cervix, Obstet Gynecol, 57, 166\nMahran, 1978, Transabdominal cervical cerclage during pregnancy. A modified technique, Obstet Gynecol, 52, 502\nLesser, 1998, Transabdominal cerclage: a laparoscopic approach, Obstet Gynecol, 91, 855\nScibetta, 1998, Laparoscopic transabdominal cervicoisthmic cerclage, Fertil Steril, 69, 161, 10.1016\u002FS0015-0282(97)00444-5\nBarmat, 2007, Da Vinci-assisted abdominal cerclage, Fertil Steril, 88, 1437e1, 10.1016\u002Fj.fertnstert.2007.09.034\nWolfe, 2008, Robotic-assisted laparoscopic placement of transabdominal cerclage during pregnancy, Am J Perinatol, 25, 653, 10.1055\u002Fs-0028-1090591\nSaling, 1984, Prevention of habitual abortion and prematurity by early total occlusion of the external os uteri, Eur J Obstet Gynecol Reprod Biol, 17, 165, 10.1016\u002F0028-2243(84)90140-0\nSchulze, 2008, Results of early total cervix occlusion (ETCO) according to Saling in multiple pregnancies: a retrospective study of the period 1995 to 2005, Z Geburtshilfe Neonatol, 212, 13, 10.1055\u002Fs-2008-1004688\nAcharya, 2006, Noninvasive cerclage for the management of cervical incompetence: a prospective study, Arch Gynecol Obstet, 273, 283, 10.1007\u002Fs00404-005-0082-2\nArabin, 2003, Is treatment with vaginal pessaries an option in patients with a sonographically detected short cervix?, J Perinat Med, 31, 122, 10.1515\u002FJPM.2003.017\nForster, 1986, Therapy of cervix insufficiency-cerclage or support pessary?, Zentralbl Gynakol, 108, 230\nGmoser, 1991, The support pessary-a therapeutic possibility in premature opening of the uterine cervix, Gynakol Rundsch, 31, 117, 10.1159\u002F000271699\nKhan, 2004, Is cervical pessary an answer to preterm delivery?, J Obstet Gynaecol, 24, 176, 10.1080\u002F01443610410001648313\nNewcomer, 2000, Pessaries for the treatment of incompetent cervix and premature delivery, Obstet Gynecol Surv, 55, 443, 10.1097\u002F00006254-200007000-00023\nPractice Bulletin A.C.O.G. Cervical insufficiency. Obstet Gynecol 2003; 102:1091–9.\nHarger, 2002, Cerclage and cervical insufficiency: an evidence-based analysis, Obstet Gynecol, 100, 1313\nDanforth, 1962, Cervical incompetence. A re-evaluation, Postgrad Med, 32, 345, 10.1080\u002F00325481.1962.11692700\nHillier, 1988, A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity, N Engl J Med, 319, 972, 10.1056\u002FNEJM198810133191503\nRomero, 1988, Infection and preterm labor, Clin Obstet Gynecol, 31, 553, 10.1097\u002F00003081-198809000-00006\nCharles, 1981, Infectious complications of cervical cerclage, Am J Obstet Gynecol, 141, 1065, 10.1016\u002FS0002-9378(16)32698-9\nBacchus, 1970, Shirodkar suture. A review of 10 years’ experience, Am J Obstet Gynecol, 108, 250, 10.1016\u002F0002-9378(70)90306-6\nAarnoudse, 1979, Complications of cerclage, Acta Obstet Gynecol Scand, 58, 255, 10.3109\u002F00016347909154044\nBates, 1977, Complication of cervical cerclage, Lancet, 2, 1035, 10.1016\u002FS0140-6736(77)92941-5\nUlmsten, 1977, Complication of cervical cerclage, Lancet, 2, 1350, 10.1016\u002FS0140-6736(77)90389-0\nHervet E, Glaser H. Traitement chirurgical des béances cervicales. EMC (Elsevier Masson SAS, Paris), Techniques chirurgicales - Urologie-Gynécologie, 41-690, 1969 : 10p.",{"ES":1593},"Técnicas quirúrgicas de cerclaje del cuello uterino",{"VOID":1595},"10.1016\u002Fs1283-081x(17)85968-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X17859683",[1598,1625,1644,1663,1678],{"id":1599,"sortIndex":115,"researcher":26,"roles":1600,"affiliations":1601,"properties":1622},"5985eb12-c764-4c68-8b8a-38dfeb588980",[696],[1602,1612],{"id":1603,"sortIndex":115,"affiliation":1604,"properties":1611},"18295565-72cf-4679-b7a6-91c2cefcdd35",{"id":1605,"createTime":1606,"updateTime":1606,"relativeEntities":1607,"slug":26,"properties":1608,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"94643268-b19e-4e80-993c-2de560bbcd65","2023-12-27T23:31:41.500+00:00",[],{"title":1609},{"VI":1610},"Service de gynécologie-obstétrique et médecine de la reproduction, Hôpital Bicêtre, 78, rue du Général-Leclerc, 94275 Le Kremlin-Bicêtre, France",{},{"id":26,"sortIndex":36,"affiliation":1613,"properties":26},{"id":1614,"createTime":1615,"updateTime":1616,"relativeEntities":1617,"slug":1618,"properties":1619,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"0afe69b4-0b07-49a4-a77e-aeb7c7b9977d","2023-12-27T23:31:41.495+00:00","2025-06-11T23:53:07.453+00:00",[],"Inserm-Centre-de-recherche-en-%C3%A9pid%C3%A9miologie-et-sant%C3%A9-des-populations-CESP-U1018-Reproduction-et-d%C3%A9veloppement-de-l-enfant-94807-Villejuif-France",{"title":1620},{"VI":1621},"Inserm, Centre de recherche en épidémiologie et santé des populations (CESP), U1018, Reproduction et développement de l’enfant, 94807 Villejuif, France",{"title":1623},{"VI":1624},"P. Capmas",{"id":1626,"sortIndex":59,"researcher":26,"roles":1627,"affiliations":1628,"properties":1641},"5df74ce0-44e2-4af0-a6f6-af342e05410f",[696],[1629,1636],{"id":1630,"sortIndex":115,"affiliation":1631,"properties":1635},"56fbbdf1-6591-4733-86bc-d2d7bc5a37f3",{"id":1605,"createTime":1606,"updateTime":1606,"relativeEntities":1632,"slug":26,"properties":1633,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1634},{"VI":1610},{},{"id":26,"sortIndex":36,"affiliation":1637,"properties":26},{"id":1614,"createTime":1615,"updateTime":1616,"relativeEntities":1638,"slug":1618,"properties":1639,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1640},{"VI":1621},{"title":1642},{"VI":1643},"M.-V. Senat",{"id":1645,"sortIndex":36,"researcher":26,"roles":1646,"affiliations":1647,"properties":1660},"6db7a7be-877e-4d01-935c-e45535cccf39",[696],[1648,1655],{"id":1649,"sortIndex":115,"affiliation":1650,"properties":1654},"87a5d85a-af33-4633-bfbb-d0bebd03a16b",{"id":1605,"createTime":1606,"updateTime":1606,"relativeEntities":1651,"slug":26,"properties":1652,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1653},{"VI":1610},{},{"id":26,"sortIndex":36,"affiliation":1656,"properties":26},{"id":1614,"createTime":1615,"updateTime":1616,"relativeEntities":1657,"slug":1618,"properties":1658,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1659},{"VI":1621},{"title":1661},{"VI":1662},"F. Fuchs",{"id":1664,"sortIndex":114,"researcher":26,"roles":1665,"affiliations":1666,"properties":1675},"eb5696f4-8ef7-4d92-9ee4-20d7513a3b00",[696],[1667],{"id":26,"sortIndex":36,"affiliation":1668,"properties":26},{"id":1669,"createTime":1670,"updateTime":1670,"relativeEntities":1671,"slug":26,"properties":1672,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"36015074-fc07-49a8-8080-bf56defe313e","2024-01-14T01:09:56.446+00:00",[],{"title":1673},{"VI":1674},"Service de gynécologie-obstétrique et médecine de la reproduction, Hôpital Antoine-Béclère, 157, rue de la Porte-de-Trivaux, 92140 Clamart, France",{"title":1676},{"VI":1677},"X. Deffieux",{"id":1679,"sortIndex":111,"researcher":26,"roles":1680,"affiliations":1681,"properties":1694},"ab2c682d-5ae0-4bb1-bcf3-9dcd0abbeefe",[696],[1682,1689],{"id":1683,"sortIndex":115,"affiliation":1684,"properties":1688},"bc757a49-3c41-40c6-bbce-b591c81110ba",{"id":1605,"createTime":1606,"updateTime":1606,"relativeEntities":1685,"slug":26,"properties":1686,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1687},{"VI":1610},{},{"id":26,"sortIndex":36,"affiliation":1690,"properties":26},{"id":1614,"createTime":1615,"updateTime":1616,"relativeEntities":1691,"slug":1618,"properties":1692,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1693},{"VI":1621},{"title":1695},{"VI":1696},"H. Fernandez",{"url":1596,"publisher":1698,"properties":1706},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1699,"slug":662,"properties":1700,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1703,"manageAffiliations":1704,"indexDatabases":1705,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1701,"title":1702},{"VOID":665},{"EN":667},[],[],[],{"volume":1707,"pages":1709},{"VOID":1708},"53",{"VOID":761},"2017-09-01",2017]